NO135243B - - Google Patents

Download PDF

Info

Publication number
NO135243B
NO135243B NO3005/70A NO300570A NO135243B NO 135243 B NO135243 B NO 135243B NO 3005/70 A NO3005/70 A NO 3005/70A NO 300570 A NO300570 A NO 300570A NO 135243 B NO135243 B NO 135243B
Authority
NO
Norway
Prior art keywords
general formula
styryl
residue
lower alkyl
dimethylaminoethoxy
Prior art date
Application number
NO3005/70A
Other languages
Norwegian (no)
Other versions
NO135243C (en
Inventor
E Mueller
R Maier
W Diederen
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO135243B publication Critical patent/NO135243B/no
Publication of NO135243C publication Critical patent/NO135243C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C07C39/20Hydroxy-styrenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)

Description

Denne oppfinnelse angår en analogifremgangsmåt for fremstilling av nye terapeutisk aktive |3-aryl-2-aminoalkoksy-styrener med den generelle formel I This invention relates to an analogous process for the preparation of new therapeutically active |3-aryl-2-amino alkoxystyrenes of the general formula I

og deres fysiologisk forlikelige syreaddisjonssalter med uorganiske og organiske syrer. and their physiologically compatible acid addition salts with inorganic and organic acids.

I denne formel betyr: In this formula means:

Ar en fenylrest, en 2-, 3- eller 4-pyridylrest, som eventuelt kan være substituert med en eller to lavere alkylgrupper, en 2-kinolyl eller 2-pyrazinylrest, som eventuelt kan være substituert med en lavere alkylgruppe, en pyrimidylrest som eventuelt kan være substituert med en lavere alkylgruppe, en 2-benzimidazolylrest som eventuelt kan være substituert med 3t halogenatom og/eller med en lavere alkylgruppe og/eller en trifluormetylgruppe, en 2-furyl- eller 2-tienylrest, en 5-isoksazolylrest som eventuelt kan være substituert med en lavere alkylgruppe eller en fenylgruppe, eller en 5-(1,2,4-oksadiazolyl)-rest som eventuelt kan være substituert med en lavere alkylgruppe, og Ar is a phenyl residue, a 2-, 3- or 4-pyridyl residue, which may optionally be substituted with one or two lower alkyl groups, a 2-quinolyl or 2-pyrazinyl residue, which may optionally be substituted with a lower alkyl group, a pyrimidyl residue which may optionally may be substituted with a lower alkyl group, a 2-benzimidazolyl residue which may optionally be substituted with a 3t halogen atom and/or with a lower alkyl group and/or a trifluoromethyl group, a 2-furyl- or 2-thienyl residue, a 5-isoxazolyl residue which may optionally be substituted with a lower alkyl group or a phenyl group, or a 5-(1,2,4-oxadiazolyl) residue which may optionally be substituted with a lower alkyl group, and

Rl' R2°^ R4 som kan være li^e eller forskjellige, hydrogenatomer eller lavere alkylgruppe, Rl' R2°^ R4 which may be the same or different, hydrogen atoms or lower alkyl group,

R^ et hydrogenatom eller en lavere alkoksygruppe, R^ a hydrogen atom or a lower alkoxy group,

R b og R_/, som er like eller forskjellige, hydrogenatomer eller lavere alkyl-, alkenyl-, hydroksyalkyl-, alkoksyalkyl- eller aralkylrester, R b and R_/, which are the same or different, hydrogen atoms or lower alkyl, alkenyl, hydroxyalkyl, alkoxyalkyl or aralkyl residues,

hvor restene Rg og R^ sammen med det mellomliggende nitrogenatom også kan danne en piperidin-, morfolin- eller metylpiperazinring, og where the residues Rg and R^ together with the intermediate nitrogen atom can also form a piperidine, morpholine or methylpiperazine ring, and

n e~r 0 eller 1. n e~r 0 or 1.

De nye forbindelser med formel I fremstilles i henhold til oppfinnelsen: 1) Ved avspaltning av vann fra forbindelsene med den generelle for mel II The new compounds of formula I are produced according to the invention: 1) By separating water from the compounds with the general flour II

hvor restene Ar, R^ til R^ og n har de ovenfor angitte betydninger. Avspaltningen av vann foretas med egnede midler, f.eks. med fosforsyre, polyfosforsyrer, fpsforsyre med fosforpentoksyd eller svovelsyre; og det har vist seg særlig hensiktsmessig å anvende where the residues Ar, R^ to R^ and n have the meanings indicated above. The separation of water is carried out with suitable means, e.g. with phosphoric acid, polyphosphoric acids, phosphoric acid with phosphorous pentoxide or sulfuric acid; and it has proven particularly appropriate to use

85&ig fos forsyre. Reaksj onen foregår ved forhøyede temperaturer, :;■'[ fortrinnsvis i området mellom 70 og 130°C. 2) Ved omsetning av en fosfonsyreester med den generelle formel III, hvor og Ar har de ovenfor angitte betydninger, og Rg er en lavere alkylrest, med et aldehyd eller keton med den generelle formel IV 85&ig phos foracid. The reaction takes place at elevated temperatures, preferably in the range between 70 and 130°C. 2) When reacting a phosphonic acid ester with the general formula III, where and Ar have the meanings given above, and Rg is a lower alkyl residue, with an aldehyde or ketone of the general formula IV

hvor restene R2 til R? og n har de ovenfor angitte, betydninger, where the residues R2 to R? and n have the above meanings,

i nærvær av^en base'under intermediær dannelse av det tilsvarende ■ karbanion av forbindelsen med formel III.. Som baser foretrekkes alkal ihy dr ider... r s; • Omsetningen foretas i epplØsningsmidler^ Som: oppløsnings ^; midler er særlig egnet høytkokende etere, f .eks. dioksan. Om- , v setningen'kan også foretas i et-vannholdig oppløsningsmiddel, fTéksf i metanol/vann i nærvær av en uorganisk base.. Hensikts- - in the presence of^a base'under intermediate formation of the corresponding ■ carbanion of the compound of formula III.. Preferred bases are alkali ihy dr ider... r s; • The turnover is made in apple solvents^ Such as: dissolving ^; agents are particularly suitable high-boiling ethers, e.g. dioxane. The reaction can also be carried out in an aqueous solvent, e.g. in methanol/water in the presence of an inorganic base.

messig settes alkalihydridet først til fosfonsyreesteren med den generelle formel III. Etter at hydrogenutvikiingen er opphørt tilsettes hensiktsmessig aldehydet eller ketonet med formel IV conventionally, the alkali hydride is first added to the phosphonic acid ester of the general formula III. After the hydrogen evolution has ceased, the aldehyde or ketone of formula IV is suitably added

uten at det dannede karbanion isoleres på forhånd. Omsetningen foretas ved svakt forhøyede temperaturer, fortrinnsvis ved temperaturer mellom 30 og 60°C. without the formed carbanion being isolated in advance. The reaction is carried out at slightly elevated temperatures, preferably at temperatures between 30 and 60°C.

3) Ved omsetning av en fosfonsyreester med den generelle formel V 3) When reacting a phosphonic acid ester with the general formula V

O = P(OR ) .0°0£I po OT fliolløæ isbexocto i a.rinwu-j:x;\toX O = P(OR ) .0°0£I po OT fliolløæ isbexocto i a.rinwu-j:x;\toX

,111 isnrio3. slls^ns^ rffeb bøni :ta;*8sei ya«©5ao2 ne vs £.a.i irs s £:;;;,3 -■ ■.>/ ,111 isnrio3. slls^ns^ rffeb böni :ta;*8sei ya«©5ao2 ne vs £.a.i irs s £:;;;,3 -■ ■.>/

hvor restene R2 til R7 og n har de ovenfor angitte betydning^^ og Rn betyr en lavere alkylres£, med et aldehyd eller keton med den generelle formel VI ^~-->/' \ hvor Ar og S.^ er som ovenfor angitt,^i nærvær av en base under intermediær dannelse av et karbanion av forbindelsen med formel V. Srøpfeas.ef^re^ek^es iføg .„ pQ ^ ^ ^ 3n9.t3_ .£ev,,. J^l igt ^np^^h^t^o^e^^ex^^om^f .^Xs^ dioks an . Omsetningen kan imidlertid også utføres i et vannholdig opp-'.uoaa8*nia!fief*s^r..ax9.j .s*e4a.eJWo*rY*rf ^røa riXtw*--» -a/bbn iejf) o^aphøfetrr^M^j^ .rtje.4 formel VI uten f otii^gåfi.n de, isjq^råag^^j^f^^^ap^fd Qx,.karban i on av r forbin de1s en mé&. fToæmej& Vvsm Omsetningen- rut4øre.S;_.yed svakt forhøyede temperaturer, fCM<p>bcintoswi^ yedtBtjemneraturer fm§llom ;.3.0 og..60.C. 4) Véd.\oms-.e.t»ing; javlet-.styren ^med Hden generelle formel VII hvor restene Ar, R^^ til R3 er som ovenfor angitt, og X betyr et hydrogenatom eller en acetylgruppe, med et amin med den generelle formel VIII where the residues R2 to R7 and n have the meanings indicated above^^ and Rn means a lower alkyl residue, with an aldehyde or ketone of the general formula VI ^~-->/' \ where Ar and S.^ are as indicated above ,^in the presence of a base during intermediate formation of a carbanion of the compound of formula V. Srøpfeas.ef^re^ek^es added .„ pQ ^ ^ ^ 3n9.t3_ .£ev,,. J^l igt ^np^^h^t^o^e^^ex^^om^f .^Xs^ dioks an . However, the reaction can also be carried out in an aqueous solution. ^aphøfetrr^M^j^ .rtje.4 formula VI without f otii^gåfi.n de, isjq^råag^^j^f^^^ap^fd Qx,.karban i on av r forbin de1s en mé&. fToæmej& Vvsm The turnover- rut4øre.S;_.yed slightly elevated temperatures, fCM<p>bcintoswi^ yedtBtjemneratures fm§llom ;.3.0 and..60.C. 4) Véd.\oms-.e.t»ing; styrene with the general formula VII where the radicals Ar, R^^ to R3 are as indicated above, and X means a hydrogen atom or an acetyl group, with an amine of the general formula VIII

hvor restene R4 til R? har de ovenfor angitte.betydninger, og Y betyr et halogenatom, i nærvær av en base. where the residues R4 to R? has the meanings given above, and Y means a halogen atom, in the presence of a base.

Omsetningen foretas i inerte oppløsnihgsmidler som f.eks. benzen, ' klorbenzen, toluen, xylen og ved forhøyede temperaturer, fortrinnsvis ved det anvendte oppløsningsmiddels kokepunkt. Som baser kan f.eks. anvendes alkalihydroksyder eller -karbonater, fortrinnsvis imidlertid alkalialkoholater. The turnover is carried out in inert solvents such as e.g. benzene, 'chlorobenzene, toluene, xylene and at elevated temperatures, preferably at the boiling point of the solvent used. As bases, e.g. alkali hydroxides or carbonates are used, preferably, however, alkali alcoholates.

5) Ved omsetning av en forbindelse med-den-generelle formel IX 5) When converting a compound with the general formula IX

hvor restene Ar, til R^ og n har de ovenfor angitte betydninger, og Z betyr en rest som kan utskiftes med basiske rester, som f.eks. et halogenatom eller en tosylgruppe, med et amin med den generelle formel X where the residues Ar, to R^ and n have the meanings given above, and Z means a residue that can be replaced by basic residues, such as e.g. a halogen atom or a tosyl group, with an amine of the general formula X

hvor restene Rg og R7 er som ovenfor angitt. where the residues Rg and R7 are as indicated above.

Omsetningen gjennomføres i et oppløsningsmiddel i nærvær The reaction is carried out in the presence of a solvent

av et syrebindende middel. Som syrebindende middel kan anvendes uorganiske eller organiske baser eller også et overskudd av aminet med formel X, og sistnevnte kan samtidig også tjene som oppløsnings-middel. Omsetningen utføres ved forhøyede temperaturer, vanligvis ved temperaturer mellom 60 og 120°C. Hvis det anvendes et lett-flyktig amin med formel X, utføres omsetningen hensiktsmessig i et lukket kar. of an acid-binding agent. Inorganic or organic bases or an excess of the amine of formula X can be used as acid-binding agent, and the latter can also serve as a solvent at the same time. The reaction is carried out at elevated temperatures, usually at temperatures between 60 and 120°C. If a highly volatile amine of formula X is used, the reaction is conveniently carried out in a closed vessel.

6) Ved omsetning av fosforylider med den generelle formel XI 6) In the reaction of phosphorylides with the general formula XI

hvor Ar og er som ovenfor angitt, med basiske ketoner eller aldehyder med formel IV where Ar and are as indicated above, with basic ketones or aldehydes of formula IV

hvor restene R2 til R^ og n har de ovenfor angitte betydninger. Kort før de omsettes, frigjøres fosforylidene med den generelle formel XI fra de tilsvarende fosfoniumhalogenider ved hjelp av baser, f.eks. ved hjelp av alkalialkoholater. Omsetningen foretas i et oppløsningsmiddel, f.eks. i en alkohol så som etanol. Omsetningen foregår ved forhøyet temperatur mellom 40°C og det anvendte oppløsningsmiddels kokepunkt. where the residues R 2 to R 1 and n have the meanings given above. Shortly before they are reacted, the phosphorylides of the general formula XI are liberated from the corresponding phosphonium halides by means of bases, e.g. by means of alkali alcoholates. The reaction is carried out in a solvent, e.g. in an alcohol such as ethanol. The reaction takes place at an elevated temperature between 40°C and the boiling point of the solvent used.

Forbindelsene med formel I dannes i almindelighet som blandinger av sine cis- og trans-isomerer. Hvis R^ og R ? er hydrogenatomer ved fremgangsmåtealternativene 1,2, 3 og 6, dannes overveiende trans-forbindelsene. Cis- og trans-forbindelsene, særlig saltene derav, f.eks. hydrokloridene, kan adskilles fra hverandre ved fraksjonert krystallisasjon. The compounds of formula I are generally formed as mixtures of their cis and trans isomers. If R^ and R ? are hydrogen atoms in method alternatives 1,2, 3 and 6, predominantly the trans compounds are formed. The cis and trans compounds, especially their salts, e.g. the hydrochlorides, can be separated from each other by fractional crystallization.

Forbindelsene med formel I kan overføres på vanlig måte The compounds of formula I can be transferred in the usual way

til sine syreaddisjonssalter ved hjelp av uorganiske eller organiske syrer. Hvis Ar betyr en N-inneholdende heterocyklisk gruppe, er det mulig ved trinnvis nøytralisasjon å tilleire et proton bare på nitrogenatomet i den basiske sidekjede. Hvis man arbeider med et overskudd av syre, får man også saltdannelse med nitrogenatomene i de heterocykliske ringer. Som syrer er særlig egnet saltsyre, bromhydrogensyre, svovelsyre, fosforsyre, vinsyre, p-toluensulfonsyre. to their acid addition salts using inorganic or organic acids. If Ar means an N-containing heterocyclic group, it is possible by stepwise neutralization to deposit a proton only on the nitrogen atom of the basic side chain. If you work with an excess of acid, you also get salt formation with the nitrogen atoms in the heterocyclic rings. Particularly suitable acids are hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, tartaric acid, p-toluenesulfonic acid.

De forbindelser med den generelle formel II som anvendes, som utgangsmaterialer ved fremgangsmåtealternativ 1), fremstilles som følger: The compounds with the general formula II which are used as starting materials in process alternative 1) are prepared as follows:

En forbindelse med den generelle formel XIII, kondenseres med en ester med den generelle formel XIV til-et keton med den generelle formel XV f.eks. ved hjelp av natriumamid i toluen. Ketonet med den generelle formel XV reduseres deretter med komplekse hydrider, f.eks. med natriumborhydrid eller med katalytisk dannet hydrogen, til alkoholen med den generelle formel II. I formlene XIII til XV har restene til R^ og n de ovenfor angitte betydninger, og resten Rg betyr en alkylrest. Fosfonsyreestrene med den generelle formel III som anvendes ved fremgangsmåtealternativ 2, kan fremstilles ved omsetning av halogenmetylforbindelser med den generelle formel XVI A compound of the general formula XIII is condensed with an ester of the general formula XIV to a ketone of the general formula XV e.g. using sodium amide in toluene. The ketone of general formula XV is then reduced with complex hydrides, e.g. with sodium borohydride or with catalytically formed hydrogen, to the alcohol of the general formula II. In the formulas XIII to XV, the residues of R 1 and n have the meanings given above, and the residue R 2 means an alkyl residue. The phosphonic acid esters with the general formula III that are used in process alternative 2 can be prepared by reacting halomethyl compounds with the general formula XVI

hvor Ar og R1 er som ovenfor angitt, og Hal betyr et klor-, brom-eller jodatom, med trialkylfosfit ved metoden ifølge Arbusow - Michaelis (Houben-Weyl, Methoden der organischen Chemie, 4. oppi. Vol. XII, del 1, S. 433) eller med dialkylfosfitnatrium ved metoden where Ar and R1 are as indicated above, and Hal means a chlorine, bromine or iodine atom, with trialkyl phosphite by the method according to Arbusow - Michaelis (Houben-Weyl, Methoden der organischen Chemie, 4. oppi. Vol. XII, part 1, P. 433) or with dialkyl phosphite sodium by the method

ifølge Michaelis-Becker (Houben-Weyl, Methoden der organischen Chemie, 4. oppi. Vol. XII, del 1, s. 447). according to Michaelis-Becker (Houben-Weyl, Methoden der organischen Chemie, 4. oppi. Vol. XII, part 1, p. 447).

Forbindelsene med den generelle formel IV fremstilles ved basisk alkylering av forbindelser med den generelle formel The compounds of the general formula IV are prepared by basic alkylation of compounds of the general formula

ved hjelp av forbindelser med den generelle formel VIII ved hjelp av den i fremgangsmåtealternativ 4 angitte metode. Man fremstilte således de følgende forbindelser fra de tilsvarende salicylaldehyder eller 2-hydroksyacetofenoner: 2-(2-dimetylaminoetoksy)-benzaldehyd, k.p._ nc. = 110°C 2-(2-dimetylaminoetoksy)-acetofenon, k.p.Q ' Q^ = 103-105 oC 2-(3-dimetylaminopropoksy)-benzaldehyd k.p.Q Qg = 109-112°C 2-(3-dimetylaminopropoksy)-acetofenon, k.p.Q ^ = 130 C Fosfonsyreestrene med den generelle formel V som anvendes ved fremgangsmåtealternativ 3, kan fremstilles på følgende måte: Ved basisk alkylering av forbindelser med den generelle formel XVII med forbindelser med den generelle formel VIII får man ketoner eller aldehyder med den generelle formel IV. Disse omsettes med komplekse hydrider, fortrinnsvis med natriumborhydrid i metanol til de tilsvarende alkoholer og disse deretter med uorganiske syrehalogenider, f.eks.' med tionylklorid, til de tilsvarende halogenforbindelser med den generelle formel XVIII by means of compounds of the general formula VIII by means of the method indicated in method alternative 4. The following compounds were thus prepared from the corresponding salicylaldehydes or 2-hydroxyacetophenones: 2-(2-dimethylaminoethoxy)-benzaldehyde, m.p._nc. = 110°C 2-(2-dimethylaminoethoxy)-acetophenone, b.p.Q ' Q^ = 103-105 oC 2-(3-dimethylaminopropoxy)-benzaldehyde b.p.Q Qg = 109-112°C 2-(3-dimethylaminopropoxy)-acetophenone, b.p.Q ^ = 130 C The phosphonic acid esters with the general formula V used in process alternative 3 can be prepared in the following way: By basic alkylation of compounds with the general formula XVII with compounds with the general formula VIII, ketones or aldehydes with the general formula IV are obtained . These are reacted with complex hydrides, preferably with sodium borohydride in methanol to the corresponding alcohols and these then with inorganic acid halides, e.g. with thionyl chloride, to the corresponding halogen compounds of the general formula XVIII

hvor restene R2 til R7 og n har de ovenfor angitte betydninger, og Hal betyr et halogenatom, fortrinnsvis et klor- eller bromatom. Forbindelsene med formel XVIII utfelles vanligvis i godt krystallisert tilstand, og foreligger som halogenhydrogensure where the radicals R 2 to R 7 and n have the meanings given above, and Hal means a halogen atom, preferably a chlorine or bromine atom. The compounds of formula XVIII usually precipitate in a well-crystallized state, and are present as halogen hydrogen acids

salter. Disse salter omsettes i et inert oppløsningsmiddel, som f.eks. i benzen, med den pr. mol beregnede dobbelte mengde av di-alkylfosfit-natrium ved metoden ifølge Michaelis-Becker (Houben- salts. These salts are reacted in an inert solvent, such as e.g. in benzene, with the pr. mol calculated twice the amount of di-alkyl phosphite sodium by the method according to Michaelis-Becker (Houben-

Weyl, Methoden der organischen Chemie, 4. oppi., Vol. XII, del 1, Weyl, Methoden der organischen Chemie, 4. oppi., Vol. XII, part 1,

s. 447) til forbindelser med den generelle formel V. p. 447) to compounds of the general formula V.

Forbindelsene med den generelle formel VII som anvendes ved fremgangsmåtealterantiv 4, kan fremstilles ved anvendelse av kjente metoder (jfr. L. Horwitz, J. Org. Chem. 21, 1039-1041 [1956]). Forbindelsene med den generelle formel VIII er kjent fra litteraturen eller de kan fremstilles i analogi med kjente metoder. The compounds of the general formula VII used in process alternative 4 can be prepared using known methods (cf. L. Horwitz, J. Org. Chem. 21, 1039-1041 [1956]). The compounds of the general formula VIII are known from the literature or they can be prepared by analogy with known methods.

Utgangsforbindelsene med den generelle formel IX som anvendes ved fremgangsmåtealternativ 5, kan fremstilles f.eks. ved omsetning av de tilsvarende 2- (2-acetoksystyryl)-arytforbindelser med benzensul-fonsyre-2-halogenetylestere i nærvær av kaliummetylat i toluen. Således ble f.eks. de følgende utgangsforbindelser fremstilt: 2-[2-(2-kloretoksy)styryl]-pyridin, sm.p. 57-59°C, The starting compounds with the general formula IX used in process alternative 5 can be prepared, e.g. by reacting the corresponding 2-(2-acetoxystyryl)-aryt compounds with benzenesulfonic acid 2-haloethyl esters in the presence of potassium methylate in toluene. Thus, e.g. the following starting compounds prepared: 2-[2-(2-chloroethoxy)styryl]-pyridine, m.p. 57-59°C,

2-[2-(2-kloretoksy)styryl]-kinolin, sm.p. av hydrokloridet 200-202°C. 2-[2-(2-chloroethoxy)styryl]-quinoline, m.p. of the hydrochloride 200-202°C.

Fosfoniumhalogenidene som ligger til grunn for fosforylidene med formel XI som anvendes ved fremgangsmåtealternativ 6, fremstilles ved innvirkning av trifenylfosfin på halogenmetylforbindelsem med den generelle formel The phosphonium halides which form the basis of the phosphorylides of formula XI used in process alternative 6 are produced by the action of triphenylphosphine on the halogenmethyl compound of the general formula

Således ble f.eks. (3,5-dimetyl-isoksazolyl-4)-metyl-trifenylfosfon-iumklorid fremstilt fra 3,5-dimetyl-4-klormetylisoksazol og trifenyl-fosf in i et utbytte på 89% av det teoretiske i form av fargeløse krystaller. Thus, e.g. (3,5-dimethyl-isoxazolyl-4)-methyl-triphenylphosphonium chloride prepared from 3,5-dimethyl-4-chloromethylisoxazole and triphenyl-phosphine in a yield of 89% of the theoretical in the form of colorless crystals.

Forbindelsene med den generelle formel I er i besittelse av verdifulle farmakologiske "egenskapr. De virker særlig smertestillende uten de bivirkninger som morfin har, og dessuten har de en god bedøv-ende og muskelavslappende virkning. . Den forbindelse som er funnet å ha best smertestillende og antiarytmisk virkning, er 2-[o-(2-dimetylaminoetoksy)styryl]-pyridin og salter av denne. The compounds of the general formula I possess valuable pharmacological properties. They have a particularly analgesic effect without the side effects of morphine, and furthermore they have a good anesthetic and muscle relaxant effect. The compound which has been found to have the best analgesic and antiarrhythmic action, is 2-[o-(2-dimethylaminoethoxy)styryl]-pyridine and its salts.

For den fysiologiske virkning er o-stillingen for den basiske sidekjede på benzenkjernen vesentlig. Således er f.eks. de kjente, isomere 4-aminoalkoksystyrener (jfr. Cavallini et al. Il Farmaco, Ed. Sei. 9, 405415 [1954] og P. Montegazza et al., For the physiological effect, the o-position of the basic side chain on the benzene nucleus is essential. Thus, e.g. the known, isomeric 4-aminoalkoxystyrenes (cf. Cavallini et al. Il Farmaco, Ed. Sei. 9, 405415 [1954] and P. Montegazza et al.,

Arch. intern, pharmacodyn. 103, 371-309) overhodet ikke smertestillende. I henhold til litteraturen har disse en antinikotin- Arch. internal, pharmacodyn. 103, 371-309) not a painkiller at all. According to the literature, these have an antinicotine

og antihistamin-virkning. and antihistamine effect.

Forbindelsene med den generelle formel I ble undersøkt The compounds of the general formula I were investigated

med hensyn til sin smertestillende virkning ved varmeplatemetoden ifølge Chen og. Beckmånn, Science 113, 1951, side 631. Grupper på hver 10 mus ble da utsatt for en varmesmerte ved å bli anbrakt på with regard to its analgesic effect by the hot plate method according to Chen et. Beckmånn, Science 113, 1951, page 631. Groups of every 10 mice were then exposed to a heat pain by being placed on

en varmeplate med en temperatur på 56°C. Dyrene som ble anvendt ved forsøket, reagerte normalt i løpet av 20 sekunder. Den smertestillende virkning ble bedømt etter den prosentdel av forsøks-dyrene som ikke reagerte ved en bestemt dose i løpet av 50 sekunder. Verdien ED^q representerer således den dose som bevirker at 50% av musene ikke reagerer på varmesmerten etter administreringen. De aktive forbindelser ble administrert peroralt. De nye forbindelser er bare lite toksiske. Den akutte toksisitet ble bestemt på mus. Grupper på hver 10 mus fikk administrert i økende doser den a hot plate with a temperature of 56°C. The animals used in the experiment reacted normally within 20 seconds. The analgesic effect was judged by the percentage of experimental animals that did not react at a certain dose within 50 seconds. The value ED^q thus represents the dose which causes 50% of the mice not to react to the heat pain after administration. The active compounds were administered orally. The new compounds are only mildly toxic. The acute toxicity was determined in mice. Groups of 10 mice each were administered increasing doses of it

aktive forbindelse peroralt. Verdien LD^Q, dvs. den dose som førte til at 50% av musene døde innen 14 dager etter administreringen, active compound orally. The LD^Q value, i.e. the dose that caused 50% of the mice to die within 14 days of administration,

ble beregnet på grunnlag av de fundne verdier ved metoden ifølge Litchfield og Wilcoxon. was calculated on the basis of the values found by the method according to Litchfield and Wilcoxon.

De følgende forbindelser er særlig sterkt smertestillende: 2- 12-(2-dimetylaminoetoksy)styrylIpyrazin-monohydroklorid; 2-[2-(2-dimetylaminoetoksy)styrylJkinolin-monohydroklorid, 2- 12-(2-dimetylaminoetoksy)styryl[-6-metyl-pyridin-monohydroklorid, 2-t 2-(2-dimetylaminoetoksy)styryllpyridin-monohydroklorid, 5-{[ 2-(2-dimetylamino)etoksy]-styryl} -3-metyl-isoksazol-hydroklorid, 5-[[2-(2-dimetylamino)etoksy]-styryl} -3-fenyl-isoksazol-hydroklorid, 2-[2-(2-dimetylaminoetoksy)styryl]-1-metylbenzimidazol-dihydroklorid, 2-(2-dimetylaminoetoksy)-stilben-hydroklorid 2- 12-(2-dimetylaminoetoksy)styrylI-furan-hydroklorid, 2-12-(2-dimetylaminoetoksy)styryl]-tiofen-hydroklorid, 1- (2-dimetylaminoetoksyfenyl)-2-(pyridyl-2-)-propen-l-monohydro-klorid, The following compounds are particularly strong analgesics: 2-12-(2-dimethylaminoethoxy)styrylpyrazine monohydrochloride; 2-[2-(2-dimethylaminoethoxy)styrylJquinoline monohydrochloride, 2- 12-(2-dimethylaminoethoxy)styryl[-6-methyl-pyridine monohydrochloride, 2-t 2-(2-dimethylaminoethoxy)styrylpyridine monohydrochloride, 5- {[ 2-(2-dimethylamino)ethoxy]-styryl}-3-methyl-isoxazole hydrochloride, 5-[[2-(2-dimethylamino)ethoxy]-styryl}-3-phenyl-isoxazole hydrochloride, 2- [2-(2-Dimethylaminoethoxy)styryl]-1-methylbenzimidazole dihydrochloride, 2-(2-dimethylaminoethoxy)stilbene hydrochloride 2- 12-(2-dimethylaminoethoxy)styrylI-furan hydrochloride, 2-12-(2- dimethylaminoethoxy)styryl]thiophene hydrochloride, 1-(2-dimethylaminoethoxyphenyl)-2-(pyridyl-2-)-propene-1-monohydrochloride,

2- [2-(2-metylaminoetoksy)styryl]pyridin-dihydroklorid og 2-[2-(2-morfolinoetoksy)styryl]pyridin-dihydroklorid. 2-[2-(2-methylaminoethoxy)styryl]pyridine dihydrochloride and 2-[2-(2-morpholinoethoxy)styryl]pyridine dihydrochloride.

Forbindelsene har ved peroral administrering en ED5Q mellom 10 og When administered orally, the compounds have an ED5Q between 10 and

60 mg/kg mus. Forbindelsene er bare lite toksiske, og således ligger f.eks. LD50-verdiene for følgende forbindelser mellom 500 60 mg/kg mouse. The compounds are only mildly toxic, and thus e.g. The LD50 values for the following compounds between 500

og 800 mg/kg mus: 2-[2-(2-dimetylaminoetoksy)styryl]-1-metyl-benzimidazol-dihydroklorid, and 800 mg/kg mouse: 2-[2-(2-dimethylaminoethoxy)styryl]-1-methyl-benzimidazole dihydrochloride,

2-(2-dimetylaminoetoksy)-stilben-hydroklorid 2-(2-Dimethylaminoethoxy)-stilbene hydrochloride

2-[2-(2-morfolinoetoksy)styryl]pyridin-dihydroklorid og 2-[2-(2-dimetylaminoetoksy)styryl]6-metyl-pyridin-hydroklorid. 2-[2-(2-morpholinoethoxy)styryl]pyridine dihydrochloride and 2-[2-(2-dimethylaminoethoxy)styryl]6-methylpyridine hydrochloride.

Eksempel 1 Example 1

20,2 g l-pyrazinyl-2-(2-dimetylaminoetoksyfenyl)-etanol-2 omrøres med 60 ml 85%ig fosforsyre, hvorved blandingen oppvarmes til 70°C. Man oppvarmer deretter i 1 time ved 110°C, oppløser blandingen i 300 ml vann etter avkjøling, nøytraliserer og metter med kaliumkarbonat. Det dannede reaksjonsprbdukt ekstraheres deretter 3 ganger med 50 ml eter hver gang, tørres over vannfritt kaliumkarbonat og filtreres med kull. Fordampningsresiduet destilleres i vakuum. Man får 13,25 g (svarende til 70,2% av det teoretiske) av en lysegul olje med kokepunkt k.p.Q 143-150°C. Oljen oppløses i 250 ml aceton og tilsettes forsiktig så mye av en oppløsning av hydrogenkloridgass i aceton at en gulfarvning akkurat begynner. Etter avkjøling i isbad utskilles hvite krystaller, 20.2 g of 1-pyrazinyl-2-(2-dimethylaminoethoxyphenyl)-ethanol-2 is stirred with 60 ml of 85% phosphoric acid, whereby the mixture is heated to 70°C. It is then heated for 1 hour at 110°C, the mixture is dissolved in 300 ml of water after cooling, neutralized and saturated with potassium carbonate. The reaction product formed is then extracted 3 times with 50 ml of ether each time, dried over anhydrous potassium carbonate and filtered with charcoal. The evaporation residue is distilled in vacuum. You get 13.25 g (corresponding to 70.2% of the theoretical) of a pale yellow oil with a boiling point c.p.Q 143-150°C. The oil is dissolved in 250 ml of acetone and carefully added enough of a solution of hydrogen chloride gas in acetone that a yellow coloration just begins. After cooling in an ice bath, white crystals are separated,

og denne mengde økes ved innrøring av 150 ml eter. Etter avsugning og tørring får man 13,9 g (svarende til 88,2% av det teoretiske basert på hydrokloriddannelsen) av 2-[2-(2-dimetylaminoetoksy)-styrylIpyrazin-monohydroklorid med sm.p. 194-195°C. and this quantity is increased by stirring in 150 ml of ether. After suction and drying, 13.9 g (corresponding to 88.2% of the theoretical based on the hydrochloride formation) of 2-[2-(2-dimethylaminoethoxy)-styrylpyrazine monohydrochloride with m.p. 194-195°C.

Den som utgangsmateriale anvendte 1-(pyrazinyl-2-)-2-(2-dimetylaminoetoksyfenyl)-etanol-2, en ikke destillerbar, gul. olje, ensartet i tynnsjiktkromatogram, fremstilles av (pyrazinyl-2-)-(2-dimetylaminoetoksyfenyl)-keton (ikke-destillerbar olje, danner et krystallisert litiumenolat) ved reduksjon med natriumborhydrid. Det nødvendige keton fremstilles av 2-metylpyrazin og 2-dimetylaminoetoksybenzoesyre-metylester ved kondensasjon med natriumamid i toluen. It used as starting material 1-(pyrazinyl-2-)-2-(2-dimethylaminoethoxyphenyl)-ethanol-2, a non-distillable, yellow. oil, uniform in thin-layer chromatogram, is prepared from (pyrazinyl-2-)-(2-dimethylaminoethoxyphenyl)-ketone (non-distillable oil, forms a crystallized lithium enolate) by reduction with sodium borohydride. The necessary ketone is prepared from 2-methylpyrazine and 2-dimethylaminoethoxybenzoic acid methyl ester by condensation with sodium amide in toluene.

Analogt med fremgangsmåten beskrevet i eksempel 1 fremstilles de følgende forbindelser (eksempel 2-7). Analogous to the method described in example 1, the following compounds are prepared (examples 2-7).

Eksempel 2 Example 2

Av 1-(kinolyl-2)-2-(2-dimetylaminoetoksyfenyl)-etanol-2, Of 1-(quinolyl-2)-2-(2-dimethylaminoethoxyphenyl)-ethanol-2,

en gul, ikke-destillerbar olje, ensartet i tynnsjiktkromatogram, fremstilles 2-t2-(2-dimetylaminoetoksy)styryl]-kinolin-monohydro-klorid med sm.p. 188°C i et utbytte på 87%. a yellow, non-distillable oil, uniform in thin-layer chromatogram, 2-t2-(2-dimethylaminoethoxy)styryl]-quinoline monohydrochloride is prepared with m.p. 188°C in a yield of 87%.

Eksempel 3 Example 3

Av 1-(6-metyl-pyridyl-2)-2-(o-dimetylaminoetoksyfenyl)-etanol-2 (lysegule krystaller, sm.p. = 228°C) fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]-6-metylpyridinmonohydroklorid med From 1-(6-methyl-pyridyl-2)-2-(o-dimethylaminoethoxyphenyl)-ethanol-2 (light yellow crystals, m.p. = 228°C) 2-[2-(2-dimethylaminoethoxy)styryl] is prepared -6-methylpyridine monohydrochloride with

smeltepunkt 200°C i et utbytte på 20%. melting point 200°C in a yield of 20%.

Eksempel 4 Example 4

Av 1(4,6-dimetylpyridyl-2)-2-(o-dimetylaminoetoksyfenyl)-etanol-2 (lysegul, ikke-destillerbar olje, ensartet i tynnsjiktkromatogram fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]-4,6-dimetylpyridindihydroklorid med smeltepunkt 177°c i et utbytte på 81%. 2-[2-(2-dimethylaminoethoxy)styryl]-4 is prepared from 1(4,6-dimethylpyridyl-2)-2-(o-dimethylaminoethoxyphenyl)-ethanol-2 (light yellow, non-distillable oil, uniform in thin-layer chromatogram), 6-dimethylpyridine dihydrochloride with melting point 177°c in a yield of 81%.

Eksempel 5 Example 5

Av 1-(2-pyridyl)-2-(2-dimetylaminoetoksyfenyl)-etanol-2, Of 1-(2-pyridyl)-2-(2-dimethylaminoethoxyphenyl)-ethanol-2,

en gul, ikke-destillerbar, i tynnsjiktkromatogram ensartet olje, fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]pyridinmonohydro- a yellow, non-distillable, thin-layer chromatogram uniform oil, 2-[2-(2-dimethylaminoethoxy)styryl]pyridine monohydro-

klorid med smeltepunkt 183°C i et utbytte på 88%. chloride with melting point 183°C in a yield of 88%.

Eksempel 6 Example 6

Av 1-(5-metylpyrazinyl-2)-2-(2-dimetylaminoetoksyfenyl)-etanol-2, en fargeløs, ikke-destillerbar, i tynnsjiktkromatogram ensartet olje, fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]-5-metylpyrazin-2-dihydroklorid, en harpiksaktig, hvit substans, From 1-(5-methylpyrazinyl-2)-2-(2-dimethylaminoethoxyphenyl)-ethanol-2, a colorless, non-distillable, thin-layer chromatogram uniform oil, 2-[2-(2-dimethylaminoethoxy)styryl]-5 -methylpyrazine-2-dihydrochloride, a resinous, white substance,

ensartet i tynnsjiktkromatogram i et utbytte på 65%. uniform in thin-layer chromatogram in a yield of 65%.

Eksempel 7 Example 7

Av 1-(4-metylpyrimidyl-6)-2-(2-dimetylaminoetoksyfenyl)-etanol-2, en ikke-destillerbar, klar, gul olje, ensartet i tynnsjiktkromatogram; fremstilles 6-[2-(2-dimetylaminoetoksy)-styryl]-4-metyl-pyrimidin med smeltepunkt 234°C i et utbytte på From 1-(4-methylpyrimidyl-6)-2-(2-dimethylaminoethoxyphenyl)ethanol-2, a non-distillable, clear, yellow oil, uniform in thin-layer chromatogram; 6-[2-(2-dimethylaminoethoxy)-styryl]-4-methyl-pyrimidine with a melting point of 234°C is produced in a yield of

87%. 87%.

Eksempel 8 Example 8

12 g av en 50%ig:'suspens jon av natriumhydrid i paraffinolje befries for vedheftende paraffinolje ved dekantering to ganger med dioksan og suspenderes i 100 ml absolutt dioksan. Denne suspensjon innføres under omrøring porsjonsvis i en oppløsning av 54 g 3-metylisoksazolyl-5-metylfosfonsyredietylester i 200 ml vannfritt dioksan, oppvarmet til en temperatur på 40 C. Etter avsluttet hydrogenutvikling omrøres i 1 time ved 50°C. Etter avkjøling til romtemperatur tilsettes dråpevis 40 g 2-(2-dimetylamino)-etoksy-benzaldehyd, og deretter oppvarmes i 1 time ved 50°C. Reaksjonsblandingen helles på is, surgjøres med 2N saltsyre og ekstraheres med eter. Eterekstrakteri kastes, den vandige fase gjøres alkalisk med fortynnet natronlut og ekstraheres med eter. Det oljeaktige residuum som man får etter tørring over natriumsulfat og avdampning av eteren, opptas i etanol, behandles med aktivt kull og tilsettes eterisk saltsyre. Etter to gangers omkrystallisering fra etanoi/ eter får man 45 g (70,5% av det teoretiske) 5-[o-(2-dimetylamino)-etoksy]styryl-3-metylisoksazol-hydroklorid i form av svakt gule krystaller med smeltepunkt 150-151°C. 12 g of a 50% suspension of sodium hydride in paraffin oil are freed from adhering paraffin oil by decanting twice with dioxane and suspended in 100 ml of absolute dioxane. This suspension is introduced, while stirring, in portions into a solution of 54 g of 3-methylisoxazolyl-5-methylphosphonic acid diethyl ester in 200 ml of anhydrous dioxane, heated to a temperature of 40°C. After completion of hydrogen evolution, stir for 1 hour at 50°C. After cooling to room temperature, 40 g of 2-(2-dimethylamino)-ethoxy-benzaldehyde are added dropwise, and then heated for 1 hour at 50°C. The reaction mixture is poured onto ice, acidified with 2N hydrochloric acid and extracted with ether. Ether extraction is discarded, the aqueous phase is made alkaline with dilute caustic soda and extracted with ether. The oily residue obtained after drying over sodium sulphate and evaporation of the ether is taken up in ethanol, treated with activated charcoal and ethereal hydrochloric acid is added. After two recrystallizations from ethanol/ether, 45 g (70.5% of the theoretical) of 5-[o-(2-dimethylamino)-ethoxy]styryl-3-methylisoxazole hydrochloride are obtained in the form of pale yellow crystals with a melting point of 150 -151°C.

Utgangsmaterialet 3-metylisoksazolyl-5-metylfosfonsyre-dietylester fremstilles i et utbytte på 84% av .det teoretiske fra 3-metyl-5-klormetylisoksazol og trietylfosfit som en gul olje med k.p. 76-80°C ved 0,0015 mm Hg. The starting material 3-methylisoxazolyl-5-methylphosphonic acid diethyl ester is prepared in a yield of 84% of the theoretical from 3-methyl-5-chloromethylisoxazole and triethyl phosphite as a yellow oil with b.p. 76-80°C at 0.0015 mm Hg.

Forbindelsen 3-metyl-5-klormetylisoksazol er kjent fra litteraturen og kan fremstilles ved fremgangsmåten ifølge G. Stagno . d'Alcontres og G. Gurrocres, Atti soc. peloritana sei. fis. mat. nat. 3, 179-86 (1956/57), [CA 52, 1994 c] fra acetonitriloksyd og propargylklorid. The compound 3-methyl-5-chloromethylisoxazole is known from the literature and can be prepared by the method according to G. Stagno. d'Alcontres and G. Gurrocres, Atti soc. Peloritana said. fart food. night 3, 179-86 (1956/57), [CA 52, 1994 c] from acetonitrile oxide and propargyl chloride.

2- (2-dimetylaminoetoksy)benzaldehyd (k.p.QQ5 = 110°C) fremstilles av salicylaldehyd og dimetylaminoetylklorid i klorbenzen i nærvær av kaliummetylat. 2-(2-dimethylaminoethoxy)benzaldehyde (b.p.QQ5 = 110°C) is prepared from salicylaldehyde and dimethylaminoethyl chloride in chlorobenzene in the presence of potassium methylate.

Analogt med fremgangsmåten beskrevet i eksempel 8, ble Analogous to the method described in example 8, was

de følgende forbindelser (eksempel 9-23) fremstilt: the following compounds (Example 9-23) prepared:

Eksempel 9 Example 9

5-[o-(2-dimetylamino)etoksy]styryl-3-fenyl-isoksazol-hydroklorid fremstilles fra (3-fenyl-isoksazolyl-5-)-metylfosfon-syre-dietylester og 2-(2-dimetylamino)etoksybenzaldehyd i et utbytte på 23,4% av det teoretiske med et smeltepunkt på 189-190°C. 5-[o-(2-dimethylamino)ethoxy]styryl-3-phenyl-isoxazole hydrochloride is prepared from (3-phenyl-isoxazolyl-5-)-methylphosphonic acid diethyl ester and 2-(2-dimethylamino)ethoxybenzaldehyde in a yield of 23.4% of the theoretical with a melting point of 189-190°C.

Den som utgangsmateriale anvendte fosfonester fremstilles fra 3-fenyl-5-brommetylisoksazol (H. G. Sen, D. Seth und U. N. Joshi, J. med. chem. 9, s. 431-33 (1966) og trietylfosfit i form The phosphon ester used as starting material is prepared from 3-phenyl-5-bromomethylisoxazole (H. G. Sen, D. Seth und U. N. Joshi, J. med. chem. 9, p. 431-33 (1966)) and triethyl phosphite in the form

av en gul, ikke-destillerbar olje. Utbytte: kvantitativt. of a yellow, non-distillable oil. Yield: quantitative.

Eksempel 10 Example 10

5-[o-(2-dimetylamino)-etoksy]styryl-3-metyl-oksadiazol-(l,2,4)-hydroklorid fremstilles fra (3-metyloksadiazolyl-(1,2,4)-5)-metylfosfonsyredietylester og 2-(2-dimetylamino)etoksybenzaldehyd i form av fargeløse krystaller med smeltepunkt 186-188 C. Utbytte: 55% av det teoretiske. 5-[o-(2-dimethylamino)-ethoxy]styryl-3-methyl-oxadiazole-(1,2,4)-hydrochloride is prepared from (3-methyloxadiazolyl-(1,2,4)-5)-methylphosphonic acid diethyl ester and 2-(2-dimethylamino)ethoxybenzaldehyde in the form of colorless crystals with a melting point of 186-188 C. Yield: 55% of the theoretical.

Den som utgangsmateriale anvendte fosfonester fremstilles fra 3-metyl-5-klormetyloksadiazol-(l,2,4) og trietylfosfit som en gulig olje med k.p. 110-112°C ved 0,2 mm Hg. Utbytte: 48,5% av det teoretiske. The phosphon ester used as starting material is prepared from 3-methyl-5-chloromethyloxadiazole-(1,2,4) and triethyl phosphite as a yellow oil with b.p. 110-112°C at 0.2 mm Hg. Yield: 48.5% of the theoretical.

3- metyl-5-klormetyloksadiazol-(l,2,4) er kjent fra litteraturen (Fransk patent 363.235, CA 62, s. 5282 b), og kan 3-methyl-5-chloromethyloxadiazole-(1,2,4) is known from the literature (French patent 363,235, CA 62, p. 5282 b), and can

fremstilles fra acetamidoksim og kloracetylklorid. is produced from acetamidoxime and chloroacetyl chloride.

Eksempel 11 Example 11

Av l-metyl-benzimidazolyl-2-metanfosfonsyredietylester (sm.p. = 75,5 - 76,5°C) og 2-(2-dimetylaminoetoksy)benzaldehyd (k.p.Q Q5 = 110°C) fremstilles 2- 12-(2-dimetylaminoetoksy)styryl]-1-metylbenzimidazol-dihydroklorid med sm.p. 208°C med et utbytte på 45%. From 1-methyl-benzimidazolyl-2-methanephosphonic acid diethyl ester (m.p. = 75.5 - 76.5°C) and 2-(2-dimethylaminoethoxy)benzaldehyde (b.p.Q Q5 = 110°C) 2- 12-(2 -dimethylaminoethoxy)styryl]-1-methylbenzimidazole dihydrochloride with m.p. 208°C with a yield of 45%.

Eksempel 12 Example 12

Av l-fenyl-6-klor-benzimidazolyl-2-metanfosfonsyredietylester (sm.p. 140°C; hydroklorid) og 2-(2-dimetylaminoetoksy-benzaldehyd (k.p.00^ = 110°C) fremstilles 2-[2-(2-dimetylamino-etoksy) styryl] -l-fenyl-6-klor-benzimidazol-dihydroklorid (sm.p. 256 C, Utbytte: 40%). 2-[2-( 2-dimethylamino-ethoxy)styryl]-1-phenyl-6-chloro-benzimidazole dihydrochloride (m.p. 256 C, Yield: 40%).

Eksempel 13 Example 13

Av l-metyl-6-klor-benzimidazolyl-2-metanfosfonsyredietyl-estér (sm.p. 103-106°C) og 2-(2-dimetylaminoetoksy)azetofenon (k.p.QQg = 103-105°C) fremstilles 1-(l-metyl-6-klor-benzimidazolyl-(2))-2-(2-dimetylaminoetoksyfenyl)-propen-dihydroklorid (sm.p. 121°C, Utbytte: 55% av det teoretiske). From 1-methyl-6-chloro-benzimidazolyl-2-methanephosphonic acid diethyl ester (m.p. 103-106°C) and 2-(2-dimethylaminoethoxy)azetophenone (b.p. QQg = 103-105°C) is prepared 1-( 1-methyl-6-chloro-benzimidazolyl-(2))-2-(2-dimethylaminoethoxyphenyl)-propene dihydrochloride (m.p. 121°C, Yield: 55% of theory).

Eksempel 14 Example 14

Av 1-fenyl-5-trifiuormetyl-benzimidazolyl-2-metanfosfonsyredietylester (k.pvQ.13=189°C) og 2-(2-dimetylaminoetoksy)-benzaldehyd (k.p.Q 05=110°C) fremstilles 2-[2-(2-dimetylaminoetoksy)-styryl]-l-fenyl-5-trifluormetyl-benzimidazol (sm.p. 225°C; 2-[2-( 2-dimethylaminoethoxy)-styryl]-1-phenyl-5-trifluoromethyl-benzimidazole (m.p. 225°C;

Utbytte: 50% av det teoretiske. Yield: 50% of the theoretical.

Eksempel 15 Example 15

Av pyridyl-27:metanfosfonsyredietylester (k.p.Q 02=H8oC) ~ og 2-(2-dimetylaminoetoksy)-acetofenon (k.p.Q Q5 = 103-105°C) fremstilles 1-(2-pyridyl)-2-(2-dimetylaminoetoksyfenyl)-propen-1. From pyridyl-27:methanephosphonic acid diethyl ester (b.p.Q 02=H8oC) ~ and 2-(2-dimethylaminoethoxy)-acetophenone (b.p.Q Q5 = 103-105°C) 1-(2-pyridyl)-2-(2-dimethylaminoethoxyphenyl)- propene-1.

Ved fremstillingen av dihydrokloridet får man i krystal-liserende form trans^isoméren (sm.p. 196-198°C) fra aceton. I et tynnsjiktkromatogram ; (aceton/etylacetat = 1:1 på basisk aluminiumoksyd, sprøytereagens: Dragendorffs reagens) har forbindelsen en Rf=0,85. Moderluten fra fremstillingen av trans-isomeren inndampes, residuet oppløses i vann, tilsettes natronlut, 6g basen ekstraheres med eter. Etter inndampning av eterekstrakten destilleres fraksjonert. Man får cis-forbindelsen som en gulaktig-fargeløs olje (k.p. 007= 122-135°C) som i tynnsjiktkromatogram In the preparation of the dihydrochloride, the trans-isomer (m.p. 196-198°C) is obtained in crystalline form from acetone. In a thin-layer chromatogram; (acetone/ethyl acetate = 1:1 on basic aluminum oxide, spray reagent: Dragendorff's reagent) the compound has an Rf=0.85. The mother liquor from the preparation of the trans-isomer is evaporated, the residue is dissolved in water, caustic soda is added, 6g of the base is extracted with ether. After evaporation of the ether extract, it is fractionally distilled. The cis compound is obtained as a yellowish-colourless oil (b.p. 007= 122-135°C) as in thin-layer chromatogram

viser en lavere Rf-verdi (0,80) enn trans-forbindelsen. shows a lower Rf value (0.80) than the trans compound.

Eksempel 16 Example 16

Av pyridyl-2-metanfosfonsyredietylester (k.p._ n,= 118°C) Of pyridyl-2-methanephosphonic acid diethyl ester (b.p._ n,= 118°C)

0,03 0.03

og 2-(3-dimetylaminopropoksy)acetofenon (k.p.Q 4=130 C) fremstilles 1- (2-pyridyl)- 2- 12-(3-dimetylaminopropoksy)-fenylj-propen-l-dihydroklorid i trans-form, analogt med trans-forbindelsen i eksempel 15 (sm.p. = 196-197°C). Fra moderluten etter hydroklorid-krystallisasjonen isoleres cis-forbindelsen som en fargeløs olje (k.p.0 16= 143°C) I tynnsjiktkromatogram adskiller begge forbindelsene se? tydelig. Trans-forbindelse: R^= 0, "cis-forTanaTélse: R,. = 0,65 (Elueringsmiddel:■ aceton/etylacetat = 1:1 på tynnsjikt-plater av basisk aluminiumoksyd, sprøytereagens: Dragendorffs reagens). and 2-(3-dimethylaminopropoxy)acetophenone (b.p.Q 4=130 C) is prepared 1-(2-pyridyl)-2- 12-(3-dimethylaminopropoxy)-phenylj-propene-1-dihydrochloride in trans form, analogously to trans - the compound in example 15 (m.p. = 196-197°C). From the mother liquor after the hydrochloride crystallization, the cis-compound is isolated as a colorless oil (b.p.0 16= 143°C). In a thin-layer chromatogram, both compounds separate see? clearly. Trans-compound: R^= 0, "cis-forTanaTélse: R,. = 0.65 (Eluent: ■ acetone/ethyl acetate = 1:1 on thin-layer plates of basic alumina, spray reagent: Dragendorff's reagent).

Eksempel 17 Example 17

Av pyridyl-2-metanfosfonsyredietylester (k.p.Q 03=118°C) og 2- (3-dimetylaminopropoksy)-benzaldehyd fremstilles 2-[2-(3-dimetyl-aminopropoksy) styryl] pyridin i form av et glass-aktig, sprøtt dihydroklorid i et utbytte på 36% av det teoretiske. From pyridyl-2-methanephosphonic acid diethyl ester (b.p.Q 03=118°C) and 2-(3-dimethylaminopropoxy)-benzaldehyde, 2-[2-(3-dimethylaminopropoxy)styryl]pyridine is prepared in the form of a glassy, brittle dihydrochloride in a yield of 36% of the theoretical.

Eksempel 18 Example 18

Av l-metyl-6-klorbenzimidazolyl-2-metanfosfonsyredietylester (sm.p. 103-106°C) og 2-(3-dimetylaminopropoksy)-acetofenon (k.p.n .-130°C) fremstilles 1-(l-metyl-6-klor-benzimidazolyl-2)-2-(3-dimetylaminopropoksyfenyl)-propen-l-dihydroklorid. (sm.p. 211 oC; Utbytte: 48% av det teoretiske). 1-(l-Methyl-6 -chloro-benzimidazolyl-2)-2-(3-dimethylaminopropoxyphenyl)-propene-1-dihydrochloride. (m.p. 211 oC; Yield: 48% of the theoretical).

Eksempel 19 Example 19

Av benzylfosfonsyredietylester (k.p.^=148°C) og 2-(2-dimetylaminoetoksy) benzaldehyd (k.p.n ' _=11.0 C) fremstiolles 2-(2-dimetylaminoetoksy)-stilben-hydroklorid (sm.p. 199 C; From benzylphosphonic acid diethyl ester (b.p.^=148°C) and 2-(2-dimethylaminoethoxy)benzaldehyde (b.p.n ' _=11.0 C) 2-(2-dimethylaminoethoxy)-stilbene hydrochloride (m.p. 199 C) is prepared;

Utbytte: 58% av det teoretiske). Yield: 58% of the theoretical).

Eksempel 20 Example 20

Av pyridyl-2-metanfosfonsyredietylester (k.p.Q 02=118°C) Of pyridyl-2-methanephosphonic acid diethyl ester (b.p.Q 02=118°C)

og 2-(2-dietylaminoetoksy)benzaldehyd (k.p.Q 05=110°C) fremstilles 2- 12-(2-dietylaminoetoksy)styryl]pyridin-dihydroklorid (sm.p. 198°C; Utbytte: 20% av det teoretiske). and 2-(2-diethylaminoethoxy)benzaldehyde (b.p.Q 05=110°C) 2-12-(2-diethylaminoethoxy)styryl]pyridine dihydrochloride is prepared (m.p. 198°C; Yield: 20% of the theoretical).

Eksempel 21 Example 21

Av pyridyl-2-metanfosfonsyredietylester (k.p.Q 03=118°C) og 2-(2-dimetylaminoetoksy)4-metoksy-benzaldehyd (k.p.Q 03=121-125 C) fremstilles 2- 12-(2-dimetylaminoetoksy-4-metoksy)styryl]-pyridin- From pyridyl-2-methanephosphonic acid diethyl ester (b.p.Q 03=118°C) and 2-(2-dimethylaminoethoxy)4-methoxy-benzaldehyde (b.p.Q 03=121-125 C) 2- 12-(2-dimethylaminoethoxy-4-methoxy) is prepared styryl]-pyridine-

dihydroklorid (sm.p. 221°C; Utbytte: 31% av det teoretiske). dihydrochloride (m.p. 221°C; Yield: 31% of theory).

Eksempel 22 Example 22

Av 2-pyridyl-metanfosfonsyredietylester (k.p.Q 05=118°C) og 2-(2-dimetylaminoetoksy)benzaldehyd (k.p.Q 05=110°C) fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]-pyridin-monohydroklorid (sm.p. 183°C; Utbytte: 43% av det teoretiske). • 2-[2-(2-dimethylaminoethoxy)styryl]-pyridine monohydrochloride (sm .p. 183°C; Yield: 43% of the theoretical). •

Eksempel 23 Example 23

Av 2-kinolylmetanfosfonsyredietylester (k.p. =138- Of 2-quinolylmethanephosphonic acid diethyl ester (b.p. =138-

O ' 035 O'035

145 C) og 2-(2-dimetylaminoetoksybenzaldehyd (k.p. ,=110 C) 145 C) and 2-(2-dimethylaminoethoxybenzaldehyde (b.p. = 110 C)

U z UD U z UD

fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]-kinolin-monohydro-klorid (sm.p. 188°C; Utbytte: 77% av det teoretiske). 2-[2-(2-dimethylaminoethoxy)styryl]-quinoline monohydrochloride is prepared (m.p. 188°C; Yield: 77% of theory).

Eksempel 24 Example 24

I 50 ml absolutt dioksan suspenderer man 2,0 g natrium- In 50 ml of absolute dioxane, suspend 2.0 g of sodium

hydrid og tilsetter dråpevis under god omrøring i løpet av 15 hydride and add dropwise with good stirring during 15

minutter ved 28°C en oppløsning av 6,3 g 2-(2-dimetylaminoetoksy)-benzylfosfonsyredietylester, og man iakttar en middels hydrogenutvikling. Man omrører videre i 1 time og tilsetter deretter dråpevis i løpet av 15 minutter en oppløsning av 2,14 g pyridin-3-aldehyd i 20 ml absolutt dioksan, hvorved man igjen kan iaktta gassutvikling. Etter henstand natten over spalter man med is og ekstraherer reaksjonsproduktet med kloroform. Etter avdestillering av oppløsningsmidlet blir det tilbake en lysebrun olje. Man opp-løser den i etanol og utfeller hydrokloridet med eterisk saltsyre, minutes at 28°C a solution of 6.3 g of 2-(2-dimethylaminoethoxy)-benzylphosphonic acid diethyl ester, and moderate hydrogen evolution is observed. Stirring continues for 1 hour and then a solution of 2.14 g of pyridine-3-aldehyde in 20 ml of absolute dioxane is added dropwise over 15 minutes, whereby gas evolution can again be observed. After standing overnight, the mixture is split with ice and the reaction product is extracted with chloroform. After distilling off the solvent, a light brown oil remains. It is dissolved in ethanol and the hydrochloride is precipitated with ethereal hydrochloric acid,

og hydrokloridet omkrystalliseres fra etanol under anvendelse av benkull. Man får 3,0 g (svarende til 44% av det teoretiske) 3|-[ 2-(2-dimetylaminoetoksy) styrylJpyridin-dihydroklorid i form av lysegule krystaller med smeltepunkt 238°C. Forbindelsen er ensartet i tynnsjiktkromatogram (basisk aluminiumoksyd (Merck); Elueringsmiddel: etylacetat; Sprøytereagens: Dragendorffs reagens) and the hydrochloride is recrystallized from ethanol using bone charcoal. 3.0 g (corresponding to 44% of the theoretical) 3|-[ 2-(2-dimethylaminoethoxy) styrylpyridine dihydrochloride is obtained in the form of pale yellow crystals with a melting point of 238°C. The compound is uniform in thin-layer chromatogram (basic alumina (Merck); Eluent: ethyl acetate; Syringe reagent: Dragendorff's reagent)

(Rf = 0,75). (Rf = 0.75).

Den som utgangsmateriale anvendte 2-(2-dimetylaminoetoksy)-benzylfosfonsyredietylester fremstilles som følger: 2-(2-dimetylaminoetoksy)benzaldehyd reduseres med natrium- • borhydrid i metanol i 77%ig utbytte til 2-(2-dimetylaminoetoksy)-benzylalkohol (k.p._ ,=125°C), og denne omsettes med tionylklorid til 2-(2-dimetylamino» etoksy)benzylklorid-hydroklorid (sm.p.=145-147 oC). Denne forbindelse omsettes i benzen med overskudd av dietylfosfit-natrium til 2-(2-dimetylaminoetoksy)benzylfosfonsyredietylester (<k>.<p.>o8 = 140-148°C). The 2-(2-dimethylaminoethoxy)-benzylphosphonic acid diethyl ester used as starting material is prepared as follows: 2-(2-dimethylaminoethoxy)benzaldehyde is reduced with sodium • borohydride in methanol in 77% yield to 2-(2-dimethylaminoethoxy)-benzyl alcohol (b.p. _ ,=125°C), and this is reacted with thionyl chloride to 2-(2-dimethylamino»ethoxy)benzyl chloride hydrochloride (m.p.=145-147 oC). This compound is reacted in benzene with an excess of sodium diethylphosphite to 2-(2-dimethylaminoethoxy)benzylphosphonic acid diethyl ester (<k>.<p.>o8 = 140-148°C).

Analogt med fremgangsmåten beskrevet i eksempel 24 fremstilles de følgende forbindelser (eksempel 25-30): Analogous to the method described in example 24, the following compounds are prepared (examples 25-30):

Eksempel 25 Example 25

Av 2-(2-dimetylaminoetoksy)-benzylfosfonsyredietylester (k.p.0 8=140-148°C) og furfurol fremstiller man 2-[2-(2-dimetyl-aminoetoksy) styryl1 furan-hydroklorid (sm.p. 156-158°C) Utbytte: From 2-(2-dimethylaminoethoxy)-benzylphosphonic acid diethyl ester (b.p.0 8=140-148°C) and furfurol, 2-[2-(2-dimethylaminoethoxy)styryl-1 furan hydrochloride (m.p. 156-158°) is prepared C) Dividend:

22% av det teoretiske. 22% of the theoretical.

Eksempel 26 Example 26

Av 2-(2-dimetylaminoetoksy)-benzylfosfonsyredietylester (k.p.Q 8=140-148°C) og tiofen-2-aldehyd fremstiller man 2-[2-(2-dimetylaminoetoksy)styryl]tiofen-hydroklorid (sm.p. 187-188°C; From 2-(2-dimethylaminoethoxy)-benzylphosphonic acid diethyl ester (b.p.Q 8=140-148°C) and thiophene-2-aldehyde, 2-[2-(2-dimethylaminoethoxy)styryl]thiophene hydrochloride (m.p. 187- 188°C;

Utbytte: 60% av det teoretiske). Yield: 60% of the theoretical).

Eksempel 27 Example 27

Av 2-(2-dimetylaminoetoksy)^-benzylfosfonsyredietylester (k.p.Q 8=140-148°C) og 2,7-nafthyridin-4-aldehyd [Ch. Jutz et al. From 2-(2-dimethylaminoethoxy)^-benzylphosphonic acid diethyl ester (b.p.Q 8=140-148°C) and 2,7-naphthyridine-4-aldehyde [Ch. Jutz et al.

Ber. 99, 2479-2490 (1966)] fremstilles 4-[2-(2-dimetylaminoetoksy)-styryl]-2,7Hiafthyridin-dihydroklorid (sm.p. 197°C; Utbytte: 24% av det teoretiske). Pray. 99, 2479-2490 (1966)], 4-[2-(2-dimethylaminoethoxy)-styryl]-2,7Hyaphthyridine dihydrochloride (m.p. 197°C; Yield: 24% of theory) is prepared.

Eksempel 28 Example 28

Av 2-(2-dimetylaminoetoksy)benzylfosfonsyredietylester (k.p.Q 8=140-148°C) og pyridin-2-aldehyd fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]pyridin-monohydroklorid (sm.p.=183 C; Utbytte: 52% av det teoretiske). From 2-(2-dimethylaminoethoxy)benzylphosphonic acid diethyl ester (b.p.Q 8=140-148°C) and pyridine-2-aldehyde is prepared 2-[2-(2-dimethylaminoethoxy)styryl]pyridine monohydrochloride (m.p.=183 C; Yield: 52% of the theoretical).

Eksempel 29 Example 29

Av 2-(2-dimetylaminoetoksy)benzylfosfonsyredietylester (k.p._ o=140-148°C) og kinolin-2-aldehyd fremstilles 2-12-(2- 2-12-(2-

°'° o dimetylaminoetoksy)styryl]kinolin-monohydroklorid (sm.p. 188 C; Utbytte: 48% av det teoretiske). °'° o dimethylaminoethoxy)styryl]quinoline monohydrochloride (m.p. 188 C; Yield: 48% of the theoretical).

Eksempel 30 Example 30

Av 2-(2-dimetylaminoetoksy)benzylfosfonsyredietylester (k.p._ q=140-148°C) og benzaldehyd fremstilles 2-(2-dimetylamino-etoksy)' stilben-hydroklorid (sm.p. = 199 oC; Utbytte: 61% av det teoretiske). From 2-(2-dimethylaminoethoxy)benzylphosphonic acid diethyl ester (bp.q=140-148°C) and benzaldehyde, 2-(2-dimethylaminoethoxy)' stilbene hydrochloride (m.p. = 199 oC; Yield: 61% of the theoretical).

Eksempel 31 Example 31

En oppløsning av 400 g 2-(2-acetoksy-styryl)pyridin i A solution of 400 g of 2-(2-acetoxy-styryl)pyridine i

1250 ml klorbenzen tilsettes 235,5 g kaliummetylat og oppvarmes til 110°C under omrøring, hvorved det dannes en gul suspensjon. 483 g dimetylaminoetylklorid-hydroklorid ristes i en ristetrakt sammen 1250 ml of chlorobenzene is added to 235.5 g of potassium methylate and heated to 110°C with stirring, whereby a yellow suspension is formed. 483 g of dimethylaminoethyl chloride hydrochloride are shaken together in a shaking funnel

med 100 ml iskald 30%ig natronlut, og den frigjorte, oljeaktige base fraskilles og dryppes inn i suspensjonen i 6 like porsjoner i løpet av 15 minutter (den mengde dimetylaminoetylklorid som ikke benyttes, oppbevares ved 0°C for å forhindre fortidlig egenreaksjon). Man omrører i ytterligere 30 minutter ved 110°C, avkjøler deretter with 100 ml of ice-cold 30% caustic soda, and the released, oily base is separated and dripped into the suspension in 6 equal portions over the course of 15 minutes (the amount of dimethylaminoethyl chloride that is not used is stored at 0°C to prevent premature self-reaction). The mixture is stirred for a further 30 minutes at 110°C, then cooled

og tilsetter is. Etter ekstrahering med eter, tørring med vann- and add ice. After extraction with ether, drying with water-

fritt natriumsulfat og avdampning av oppløsnihgsmidlet blir det tilbake en olje som destilleres i vakuum; k.p.„ rt,=156-161°C. free sodium sulfate and evaporation of the solvent leaves an oil which is distilled in vacuum; b.p.„ rt,=156-161°C.

O, Ob O, Ob

Man får 376 g av en honningfarget olje (utbytte: 83,9% av det teoretiske). You get 376 g of a honey-coloured oil (yield: 83.9% of the theoretical).

123 g av det oljeaktige reaksjonsprodukt oppløses i en blanding av 750 ml etylacetat og 330 ml absolutt etanol. Hertil tilsetter man under god omrøring gradvis 430 ml av en oppløsning av 132 ml etanolisk saltsyre (12,72%ig vekt/volum) i 638 ml etylacetat, 123 g of the oily reaction product are dissolved in a mixture of 750 ml of ethyl acetate and 330 ml of absolute ethanol. To this, with good stirring, gradually add 430 ml of a solution of 132 ml of ethanolic hydrochloric acid (12.72% weight/volume) in 638 ml of ethyl acetate,

og ingen gulfarging bør opptre. Deretter tilsetter man 600 ml etylacetat og avkjøler til 0°C. De utskilte krystaller av 2- 12-(2-dimetylaminoetoksy)styryl]pyridin-monohydroklorid avsuges, vaskes med etylacetat og tørres i en eksikator over konsentrert svovelsyre og kaliumhydroksyd. Smeltepunkt: 186-187,5°C; and no yellowing should occur. 600 ml of ethyl acetate are then added and cooled to 0°C. The separated crystals of 2-12-(2-dimethylaminoethoxy)styryl]pyridine monohydrochloride are filtered off with suction, washed with ethyl acetate and dried in a desiccator over concentrated sulfuric acid and potassium hydroxide. Melting point: 186-187.5°C;

Utbytte ved denne saltdannelse: 93 g. Yield by this salt formation: 93 g.

Hvis man anvender et overskudd av etanolisk saltsyre, If an excess of ethanolic hydrochloric acid is used,

ialt 300 ml av saltsyren med den ovenfor angitte konsentrasjonen, farges oppløsningen dypt gul, og man isolerer dihydrokloridet av 2-[2-(2-dimetylaminoetoksy)styryl]pyridin med smeltepunkt 218-220°C. For fremstilling av p-toluensulfonatet oppløser man 2,68 g av den a total of 300 ml of the hydrochloric acid with the concentration indicated above, the solution is colored deep yellow, and the dihydrochloride of 2-[2-(2-dimethylaminoethoxy)styryl]pyridine with a melting point of 218-220°C is isolated. To prepare the p-toluenesulfonate, 2.68 g of it is dissolved

frie base av 2-/2-(2-dimetylaminoetoksy)styryl]pyridin i 20 ml absolutt etylacetat og tilsetter under omrøring langsomt 19 ml av en oppløsning av 1,72 g p-toluensulfonsyre i 20 ml etylacetat. Etter avkjøling i is utkrystalliserer mono-p-toluensulfonatet, som vaskes med litt etylacetat og tørres i eksikator over svovelsyre. Smeltepunkt: 128-130°C; Utbytte: 3,1 g. free base of 2-(2-(2-dimethylaminoethoxy)styryl]pyridine in 20 ml of absolute ethyl acetate and slowly add, with stirring, 19 ml of a solution of 1.72 g of p-toluenesulfonic acid in 20 ml of ethyl acetate. After cooling in ice, the mono-p-toluenesulfonate crystallizes out, which is washed with a little ethyl acetate and dried in a desiccator over sulfuric acid. Melting point: 128-130°C; Yield: 3.1 g.

For fremstilling av det fosforsyresalt oppløser man 2,68 g To prepare the phosphoric acid salt, 2.68 g is dissolved

av den frie base av 2-[2-(2-dimetylaminoetoksy)styrylIpyridin i 40 ml etanol og tilsetter langsomt dråpevis under omrøring en opp-løsning av 0,346 g 85%ig fosforsyre. Den fargeløse oppløsning inndampes til 25 ml, tilsettes 25 ml etylacetat og anbringes i et of the free base of 2-[2-(2-dimethylaminoethoxy)styrylpyridine in 40 ml of ethanol and slowly adding a solution of 0.346 g of 85% phosphoric acid dropwise while stirring. The colorless solution is evaporated to 25 ml, 25 ml of ethyl acetate is added and placed in a

isbad. Etter 1 time utkrystalliseres et hvitt bunnfall av fosfatet ice bath. After 1 hour, a white precipitate of the phosphate crystallizes out

av den ovennevnte base. I henhold til analysen kommer det på of the above base. According to the analysis, it comes on

1 mol base 1/3 mol fosforsyre. Smeltepunkt: 133-134°C; 1 mol base 1/3 mol phosphoric acid. Melting point: 133-134°C;

Utbytte: 1,1 g Yield: 1.1 g

Det som utgangsmateriale anvendte 2-(2-acetoksy-styryl)-pyridin (k.p.Q(06=162-175°C) ble fremstilt av 2-pikolin og salicylaldehyd i nærvær av eddiksyreanhydrid ved 170°C. The starting material 2-(2-acetoxy-styryl)-pyridine (b.p.Q(06=162-175°C)) was prepared from 2-picoline and salicylaldehyde in the presence of acetic anhydride at 170°C.

Analogt med fremgangsmåten beskrevet i eksempel 31 Analogous to the procedure described in example 31

fremstilles også de følgende forbindelser (eksempel 32-34). the following compounds are also prepared (examples 32-34).

Eksempel 32 Example 32

Av l-(2-acetoksyfenyl)-2-(pyridyl-2)-propen-l (k.p.Q 05=140°C) og dimetylaminoetylklorid fremstilles 1-(2-dimetylaminoetoksyfenyl)-2-(pyridyl-2)-propen-l-monohydroklorid. Sm.p. = 128-133°C; From 1-(2-acetoxyphenyl)-2-(pyridyl-2)-propene-1 (b.p.Q 05=140°C) and dimethylaminoethyl chloride, 1-(2-dimethylaminoethoxyphenyl)-2-(pyridyl-2)-propene-1 is prepared -monohydrochloride. Sm.p. = 128-133°C;

utbytte: 85% av det teoretiske. yield: 85% of the theoretical.

Eksempel 33 Example 33

Av 2-(2-acetoksystyryl)pyridin (k.p.Q 06=162-175°C) og 2-klor-N,N-dimetylpropylamin fremstilles 2-[2-(3-dimetylaminoprop-2-oksy)-styryl]pyridin. (k.p.Q 025=158-159°C; utbytte: 86% av det teoretiske). From 2-(2-acetoxystyryl)pyridine (b.p.Q 06=162-175°C) and 2-chloro-N,N-dimethylpropylamine, 2-[2-(3-dimethylaminoprop-2-oxy)-styryl]pyridine is prepared. (b.p. Q 025=158-159°C; yield: 86% of the theoretical).

Eksempel 34 Example 34

Av 2-(2-hydroksystyryl)kinolin (sm.p.=274-278°C) og dimetylaminoetylklorid fremstilles 2-[2-(2-dimetylaminoetoksy)styryll-kinolin-monohydroklorid (sm.p. =188°C; utbytte: 86% av det teoretiske) From 2-(2-hydroxystyryl)quinoline (m.p.=274-278°C) and dimethylaminoethyl chloride, 2-[2-(2-dimethylaminoethoxy)styryl-quinoline monohydrochloride (m.p.=188°C; yield) is prepared : 86% of the theoretical)

Eksempel 35 Example 35

16 g 2- 12-(2-kloretoksy)styryl]pyridin (sm.p.=57-59°C) 16 g 2-12-(2-chloroethoxy)styryl]pyridine (m.p.=57-59°C)

oppløses i 50 ml metanol og blandes ved -15°C med 120 ml frisk, flytende metylamin fra en bombe og oppvarmes i autoklav i 4 timer ved 80°C. Etter avkjøling og avspenning inndampes autoklav-innholdet, residuet oppløses i fortynnet eddiksyre og ristes to ganger med eter for å fjerne de svakt basiske produkter. Deretter gjøres blandingen alkalisk under avkjøling med 2N natronlut, og reaksjonsproduktet ekstraheres med etylacetat. Etter tørring med natriumsulfat blir det tilbake etter avdestillering et oljeaktig residuum som ved henstand natten over krystalliserer (13,8 g, dissolve in 50 ml of methanol and mix at -15°C with 120 ml of fresh, liquid methylamine from a bomb and heat in an autoclave for 4 hours at 80°C. After cooling and relaxation, the autoclave contents are evaporated, the residue is dissolved in dilute acetic acid and shaken twice with ether to remove the weakly basic products. The mixture is then made alkaline while cooling with 2N caustic soda, and the reaction product is extracted with ethyl acetate. After drying with sodium sulphate, an oily residue remains after distillation, which crystallizes on standing overnight (13.8 g,

svarende til 88,2% av det teoretiske). Forbindelsen oppløses i 200 ml aceton, filtreres med aktivt kull og tilsettes 20 ml etanol. corresponding to 88.2% of the theoretical). The compound is dissolved in 200 ml of acetone, filtered with activated carbon and 20 ml of ethanol is added.

Til denne blanding setter man forsiktig en oppløsning av 15,3 ml etanolisk 12,72%ig saltsyre (vekt/volum) i 50 ml aceton til en begynnende gulfarging, og til dette er det nødvendig med ca. 59 ml av den sure felleoppløsning. Man tilsetter deretter eter til begynnende uklarhet og omrører i isbad under avkjøling. I løpet av 1 time utkrystalliserer et mattgult stoff som avsuges og tørres i eksikator. Man får 9,3 g (svarende til 52% av det teoretiske) 2- 12-(2-metylaminoetoksy)styryl]pyridin-monohydroklorid med smeltepunkt 178-180°C. To this mixture, carefully add a solution of 15.3 ml of ethanolic 12.72% hydrochloric acid (weight/volume) in 50 ml of acetone until it begins to turn yellow, and for this you need approx. 59 ml of the acidic trap solution. Ether is then added until it begins to cloud and stirred in an ice bath while cooling. Within 1 hour, a dull yellow substance crystallizes out, which is suctioned off and dried in a desiccator. 9.3 g (corresponding to 52% of the theoretical) of 2-12-(2-methylaminoethoxy)styryl]pyridine monohydrochloride with a melting point of 178-180°C are obtained.

Det som utgangsmateriale anvendte 2- 12-(2-kloretoksy)-styryl]pyridin(sm.p. = 57-59°C fremstilles av 2-(2-acetoksystyryl)-pyridin (se eks. 32) og benzensulfonsyre-2-kloretylester i nærvær av kaliummetylat i toluen. The 2-12-(2-chloroethoxy)-styryl]pyridine (m.p. = 57-59°C) used as starting material is prepared from 2-(2-acetoxystyryl)-pyridine (see ex. 32) and benzenesulfonic acid-2- chloroethyl ester in the presence of potassium methylate in toluene.

Analogt med fremgangsmåten beskrevet i eksempel 35 fremstilles også de følgende forbindelser (eksempel 36-48): Analogous to the method described in example 35, the following compounds are also prepared (examples 36-48):

Eksempel 36 Example 36

Av 2- 12-(2-kloretoksy)styryl]pyridin (sm.p.=57-59°C) og ammoniakk fremstilles 2-[2-(2-aminoetoksy)styrylIpyridin-dihydroklorid (sm.p. 269°C; utbytte: 49% av det teoretiske). From 2-12-(2-chloroethoxy)styryl]pyridine (m.p.=57-59°C) and ammonia, 2-[2-(2-aminoethoxy)styryl]pyridine dihydrochloride (m.p. 269°C) is prepared; yield: 49% of the theoretical).

Eksempel 37 Example 37

Av 2-t2-(2-kloretoksy)styryl]kinolin-hydroklorid (sm.p. 214-220°C) og metylamin fremstilles 2-[2-(2-metylaminoetoksy)styryl]-kinolin-monohydroklorid (sm.p. 170°C; Utbytte: 12,0% av det teoretiske. From 2-t2-(2-chloroethoxy)styryl]quinoline hydrochloride (m.p. 214-220°C) and methylamine, 2-[2-(2-methylaminoethoxy)styryl]-quinoline monohydrochloride (m.p. 170°C; Yield: 12.0% of the theoretical.

Eksempel 38 Example 38

Av 2- 12-(2-klor-etoksy)styryl]pyridin (sm.p. 57-58°C) og etylamin fremstilles 2- 12-(etylaminoetoksy)styryl]pyridin-dihydroklorid (sm.p. 211°C; utbytte: 48,3% av det teoretiske). From 2-12-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and ethylamine, 2-12-(ethylaminoethoxy)styryl]pyridine dihydrochloride (m.p. 211°C) is prepared; yield: 48.3% of the theoretical).

Eksempel 39 Example 39

Av 2-[2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og piperidin fremstilles 2- 12-(2-piperidinoetoksy)styryl]pyridin-dihydroklorid (sm.p. 176°C; utbytte: 31% av det teoretiske). From 2-[2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and piperidine, 2-12-(2-piperidinoethoxy)styryl]pyridine dihydrochloride (m.p. 176°C) is prepared ; yield: 31% of the theoretical).

Eksempel 40 Example 40

Av 2-[2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og morfolin fremstilles 2-[2-(2-morfolinoetoksy)styryl]pyridin-dihydroklorid (sm.p. 248°C; utbytte: 53% av det teoretiske). From 2-[2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and morpholine, 2-[2-(2-morpholinoethoxy)styryl]pyridine dihydrochloride (m.p. 248°) is prepared C; yield: 53% of the theoretical).

Eksempel 41 Example 41

Av 2-[2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og N-metylpiperazin fremstilles 2- 12-(2-metylpiperazinoetoksy)styryl]-pyridin-trihydroklorid (sm.p. 268°C; utbytte: 45% av det teoretiske). From 2-[2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and N-methylpiperazine, 2-12-(2-methylpiperazineethoxy)styryl]-pyridine trihydrochloride (m.p. 268°C; yield: 45% of the theoretical).

Eksempel 42 Example 42

Av 2-t2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og allylamin fremstilles 2- 12-(2-ailylaminoetoksy)styryl]pyridin-dihydroklorid (sm.p. 201°C; utbytte: 18% av det teoretiske). From 2-t2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and allylamine, 2-12-(2-allylaminoethoxy)styryl]pyridine dihydrochloride (m.p. 201°C) is prepared; yield: 18% of the theoretical).

Eksempel 43 Example 43

Av 2-t2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og 2-f enyl et yl amin fremstilles 2-t 2-(2-/3-f enyletylaminoetoksy) styryl] - pyridin-dihydroklorid (sm.p. 263°C; utbytte: 54% av det teoretiske). From 2-t2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and 2-phenylethylamine, 2-t2-(2-/3-phenylethylaminoethoxy)styryl]- pyridine dihydrochloride (m.p. 263°C; yield: 54% of theory).

Eksempel 44 Example 44

Av 2-[2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og 2-metoksyetylamin fremstilles 2-t 2- (2-/3-metoksyetylaminoetoksy) - styryl]-pyridin-monohydroklorid (sm.p. 147°C; utbytte: 45% av det teoretiske). From 2-[2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and 2-methoxyethylamine, 2-t 2-(2-/3-methoxyethylaminoethoxy)-styryl]-pyridine monohydrochloride is prepared (m.p. 147°C; yield: 45% of the theoretical).

Eksempel 45 Example 45

Av 2-t2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og di-(2-hydroksyetyl)amin fremstilles 2-t2-(2-dihydroksyetylamino-etoksy)styryl]pyridin-dihydroklorid (sm.p. 140°C; utbytte: 22% From 2-t2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and di-(2-hydroxyethyl)amine, 2-t2-(2-dihydroxyethylaminoethoxy)styryl]pyridine dihydrochloride is prepared (m.p. 140°C; yield: 22%

av det teoretiske). of the theoretical).

Eksempel 46 Example 46

Av 2-t2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og metyl-2-hydroksyetylamin fremstilles 2-[2-(2-N-metyl-N-hydroksy-etylaminoetoksy)styryl]pyridin-dihydroklorid (sm.p. 190°C; From 2-t2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and methyl-2-hydroxyethylamine, 2-[2-(2-N-methyl-N-hydroxy-ethylaminoethoxy)styryl is prepared ]pyridine dihydrochloride (m.p. 190°C;

utbytte: 42% av det teoretiske). yield: 42% of the theoretical).

Eksempel 47 Example 47

Av 2-t2-(2-kloretoksy)styryl]pyridin (sm.p. 57-59°C) og dimetylamin fremstilles 2-t 2-(2-dimetylaminoetoksy)styryl]pyridin-monohydroklorid (sm.p. 183°C; utbytte: 68% av det teoretiske). From 2-t2-(2-chloroethoxy)styryl]pyridine (m.p. 57-59°C) and dimethylamine, 2-t 2-(2-dimethylaminoethoxy)styryl]pyridine monohydrochloride (m.p. 183°C) is prepared ; yield: 68% of the theoretical).

Eksempel 48 Example 48

Av 2-t2-(2-kloretoksy)styryl]kinolin (sm.p. 214-220°C) og dimetylamin fremstilles 2-[2-(2-dimetylaminoetoksy)styrylJkinolin-monohydroklorid (sm.p. 188°C; utbytte: 74% av det teoretiske). From 2-t2-(2-chloroethoxy)styryl]quinoline (m.p. 214-220°C) and dimethylamine, 2-[2-(2-dimethylaminoethoxy)styryl]quinoline monohydrochloride (m.p. 188°C; yield) is prepared : 74% of the theoretical).

Eksempel 49 Example 49

24,5 g (3,5-dimetylisoksazolyl-4)-metyl-trifenyl-fosfoniumklorid i 150 ml absolutt etanol settes til 1,4 g natrium i 50 ml absolutt etanol. Til reaksjonsblandingen som er oppvarmet til 40°C, settes dråpevis under omrøring 7,8 g 2-(2-dimétylamino)-etoksybenzaldehyd, og deretter oppvarmes i 15 minutter til kokning. Etter avdampning av oppløsningsmidlet opptas reaksjonsblandingen 24.5 g of (3,5-dimethylisoxazolyl-4)-methyl-triphenyl-phosphonium chloride in 150 ml of absolute ethanol is added to 1.4 g of sodium in 50 ml of absolute ethanol. 7.8 g of 2-(2-dimethylamino)-ethoxybenzaldehyde are added dropwise with stirring to the reaction mixture which has been heated to 40°C, and then heated for 15 minutes until boiling. After evaporation of the solvent, the reaction mixture is taken up

i fortynnet saltsyre og ekstraheres med benzen for å fjerne det dannede trifenylfosfinoksyd. Den vandige fase gjøres alkalisk med 2N natronlut og ekstraheres flere ganger med eter. Det oljeaktige residuum som oppnås etter tørring med natriumsulfat og avdampning in dilute hydrochloric acid and extracted with benzene to remove the triphenylphosphine oxide formed. The aqueous phase is made alkaline with 2N caustic soda and extracted several times with ether. The oily residue obtained after drying with sodium sulphate and evaporation

av eteren, oppløses i aceton, og hydrokloridet felles med eterisk saltsyre. Etter to gangers omkrystallisering fra aceton får man 6 g (70% av det teoretiske) 4-[2-(2-dimetylamino)-etoksy-styryl]-3,4-dimetylisoksazol-hydroklorid som fargeløse krystaller med smeltepunkt 180-181°C. of the ether, dissolve in acetone, and the hydrochloride precipitate with ethereal hydrochloric acid. After two recrystallizations from acetone, 6 g (70% of the theoretical) of 4-[2-(2-dimethylamino)-ethoxy-styryl]-3,4-dimethylisoxazole hydrochloride are obtained as colorless crystals with a melting point of 180-181°C .

Det som utgangsmateriale anvendte fosfoniumklorid fremstilles av 3,5-dimetyl-4-klormetylisoksazol og trifenylfosfit med et utbytte på 89% av det teoretiske, i form av fargeløse krystaller. The phosphonium chloride used as starting material is prepared from 3,5-dimethyl-4-chloromethylisoxazole and triphenylphosphite with a yield of 89% of the theoretical, in the form of colorless crystals.

3,5-dimetyl-4-klormetylisoksazol kan fremstilles ifølge N.K. Kochetkov, E. D. Khomutova og M. V. Bazilevsky, J. Gen. Chem. (USSR) 28, 2736 (1958) ved klormetylering av 3,5-dimetyl-isoksazol. 3,5-dimethyl-4-chloromethylisoxazole can be prepared according to N.K. Kochetkov, E. D. Khomutova and M. V. Bazilevsky, J. Gen. Chem. (USSR) 28, 2736 (1958) by chloromethylation of 3,5-dimethylisoxazole.

Analogt med fremgangsmåten beskrevet i eksempel 49 fremstilles også de følgende forbindelser (eksempel 50-51): Analogous to the method described in example 49, the following compounds are also prepared (examples 50-51):

Eksempel 50 Example 50

Av benzylklorid og trifenylfosfin fremstilles benzyl-trifenylfosfoniumklorid [Wittig og SchSllkopf, Ber. 88, 1662 From benzyl chloride and triphenylphosphine, benzyl-triphenylphosphonium chloride is prepared [Wittig and Schlllkopf, Ber. 88, 1662

(1955)], og dette omsettes med 2-(dimetylaminoetoksy)benzaldehyd (k.p. ,=110°C) til 2-(dimetylaminoetoksy)stilben. Forbindelsen (1955)], and this is reacted with 2-(dimethylaminoethoxy)benzaldehyde (b.p.=110°C) to 2-(dimethylaminoethoxy)stilbene. The connection

0,05 o 0.05 o

isoleres som hydroklorid (sm.p. 199 C; utbytte: 73% av det teoretiske). is isolated as hydrochloride (m.p. 199 C; yield: 73% of the theoretical).

Eksempel 51 Example 51

Av 2-klor-metylpyridin (k.p.1=42-45°C) og trifenylfosfin fremstilles pikolyl-2-trifenylfosfoniumklorid og dette omsettes From 2-chloro-methylpyridine (b.p.1=42-45°C) and triphenylphosphine, picolyl-2-triphenylphosphonium chloride is prepared and this is reacted

med 2-(dimetylaminoetoksy)benzaldehyd (k.p.Q 05=110°C) til 2-[2-(2-dimetylaminoetoksy)styryl]pyridin, og dette isoleres som mono-hydrokloridet (sm.p. 186-187°C; utbytte: 66% av det teoretiske). with 2-(dimethylaminoethoxy)benzaldehyde (b.p.Q 05=110°C) to 2-[2-(2-dimethylaminoethoxy)styryl]pyridine, and this is isolated as the mono-hydrochloride (m.p. 186-187°C; yield: 66% of the theoretical).

Claims (2)

1. Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive 8-aryl-2-aminoalkoksystyrener med den generelle formel hvor Ar betyr en fenylrest, en 2-, 3- eller 4-pyridylrest, som eventuelt kan være substituert med én eller to lavere alkylgrupper, en 2-kinolyl eller 2-pyrazinylrest, som eventuelt kan være substituert med en lavere alkylgruppe, en pyrimidylrest som eventuelt kan være substituert med en lavere alkylgruppe, en 2-benzimidazolylrest som eventuelt kan være substituert med et halogenatom og/eller med en lavere alkylgruppe og/eller en trifluormetylgruppe, en 2-furyl-eller 2-tienylrest, en 5-isoksazolylrest som eventuelt kan være substituert med en lavere alkylgruppe eller en fenylgruppe, eller en 5-(1,2,4-oksadiazolyl)-rest som eventuelt kan være substituert med en lavere alkylgruppe, Rl' R2°^ R4' sortl er ^^ ie eHer forskjellig fra hverandre, betyr hydrogenatomer eller lavere alkylgrupper, R- betyr et hydrogenatom eller en lavere alkoksygruppe, Rfi og R7, som er like eller forskjellig fra hverandre, betyr hydrogenatomer eller lavere alkyl-, alkenyl-, hydroksyalkyl-, alkoksyalkyl- eller aralkyl-grupper, idet restene R^ og R^ også sammen med det mellomliggene nitrogenatom kan danne en piperidin-, morfolin- eller metylpiperazinring, og n betyr 0 eller 1, og deres syreaddisjonssalter med uorganiske eller organiske syrer, karakterisert ved at a) fra en forbindelse med den generelle formel hvor restene Ar, R^ til R^, R&, R? og n har de ovenfor angitte betydninger, avspaltes vann ved hjelp av vanntiltrekkende midler ved forhøyet temperatur, eller b) en fosfonsyreester med den generelle formel hvor R1 og Ar har de ovenfor angitte betydninger, og R betyr en lavere alkylgruppe, omsettes i et oppløsningsmiddel med et aldehyd eller keton med den generelle formel hvor restene R^ til ^4» Rg< R7°9 n nar ^e ovenfor angitte betydninger, i nærvær av en base, under intermediær dannelse av et tilsvarende karbanion av forbindelsen med den generelle formel III, eller c) en fosfonsyreester med den generelle formel ,. _,hyo55Tgestgn^aR2 ^fcriic*^» &Rg-/ sB-j^g^i/haas-^eiioQveaaiéar nangtUitee? bete<y>d-njnger/^ og«.Rg.^etyr,.r.en3lrave]?;g a^yjigrtrøpjejsQmseifct^ Lav et oppløsningsmiddel med et aldehyd eller keton med den generelle formel Hvor Ar -og!:'-R£: -h.ar: dé! 'évé^o^åVig^rÉt^^e^y^diyi-hgér ^Såf^år a'v^<v>én base, under inttérmédiåir ^ QårfåéSsé-^ év^& t' .k^uSJÆiflS^dW^v^^orbindelsen med den generelle formel V, eller d) et styren med den generelle f or mel1- i hvor restene Ar og R^ til R^ har de ovenfor angitte betydninger,og X er et hydrogenatom eller en acetylgruppe, omsettes i nærvær av en base og et oppløsningsmiddel med et amin med den generelle formel hvor restene R^, R^ og R7 har de ovenfor angitte betydninger, og Y betyr et halogenatom, eller e) en forbindelse med den generelle formel ,,..... ,. hyor restene Ar; R, til R4 og n har de ovenfor angitte betydninger, og Z betyr en rest som kan utskiftes med basiske rester, omsettes ved forhøyede temperaturer med et amin med den generell formel hvor restene og har de ovenfor angitte betydninger, eller -'tim/rf-), et fosfbr<y>lid med den generelle formel hvor Ar og R^ har -de ovenfor angitte betydninger, omsettes i et oppløsningsmiddel ved forhøyede temperaturer med et basisk keton eller aldehyd med den generelle formel hvor restene R^ til R^, R^ og R^ og n har de ovenfor angitte betydninger, og eventuelt adskilles deretter en eventuelt dannet blanding av cis- og trans-isomerene ved fraksjonert krystallisasjon, og/eller eventuelt' overføres den erholdt forbindelse med formel I til sitt syreaddisjonssalt ved hjelp av en uorganisk eller organisk syre.1. Analogy method for the preparation of new, therapeutically active 8-aryl-2-amino alkoxystyrenes with the general formula where Ar means a phenyl residue, a 2-, 3- or 4-pyridyl residue, which may optionally be substituted with one or two lower alkyl groups, a 2-quinolyl or 2-pyrazinyl residue, which may optionally be substituted with a lower alkyl group, a pyrimidyl residue which may optionally be substituted with a lower alkyl group, a 2-benzimidazolyl residue which may optionally be substituted with a halogen atom and/or with a lower alkyl group and/or a trifluoromethyl group, a 2-furyl or 2-thienyl residue, a 5-isoxazolyl residue which may optionally may be substituted with a lower alkyl group or a phenyl group, or a 5-(1,2,4-oxadiazolyl) residue which may optionally be substituted with a lower alkyl group, Rl' R2°^ R4' sortl is ^^ ie eHer different from each other, means hydrogen atoms or lower alkyl groups, R- means a hydrogen atom or a lower alkoxy group, Rfi and R7, which are the same or different from each other, mean hydrogen atoms or lower alkyl, alkenyl, hydroxyalkyl, alkoxyalkyl or aralkyl groups, the residues R^ and R^ also together with the intermediate nitrogen atom can form a piperidine- , morpholine or methylpiperazine ring, and n means 0 or 1, and their acid addition salts with inorganic or organic acids, characterized in that a) from a compound of the general formula where the residues Ar, R^ to R^, R&, R? and n has the meanings given above, water is split off using water-attracting agents at elevated temperature, or b) a phosphonic acid ester of the general formula where R1 and Ar have the meanings given above, and R means a lower alkyl group, is reacted in a solvent with an aldehyde or ketone of the general formula where the residues R^ to ^4» Rg< R7°9 n nar ^e meanings indicated above, in the presence of a base, with intermediate formation of a corresponding carbanion of the compound of the general formula III, or c) a phosphonic acid ester of the general formula ,. _,hyo55Tgestgn^aR2 ^fcriic*^» &Rg-/ sB-j^g^i/haas-^eiioQveaaiéar nangtUitee? bete<y>d-njnger/^ and«.Rg.^ethyr,.r.en3lrave]?;g a^yjigrtrøpjejsQmseifct^ Prepare a solvent with an aldehyde or ketone of the general formula Where Ar -og!:'-R£: -h.ar: dé! 'évé^o^åVig^rÉt^^e^y^diyi-hgér ^Såf^år a'v^<v>én base, under inttérmédiåir ^ QårfåéSsé-^ év^& t' .k^uSJÆiflS^dW^v ^^the compound with the general formula V, or d) a styrene of the general formula mel1-i where the radicals Ar and R^ to R^ have the meanings given above, and X is a hydrogen atom or an acetyl group, is reacted in the presence of a base and a solvent with an amine of the general formula where the radicals R^, R^ and R7 have the meanings given above, and Y means a halogen atom, or e) a compound with the general formula ,,..... ,. hyor the residues Ar; R, to R4 and n have the meanings given above, and Z means a radical which can be replaced by basic radicals, reacted at elevated temperatures with an amine of the general formula where the residues and have the meanings given above, or -'tim/rf-), a phospholide with the general formula where Ar and R^ have the meanings given above, are reacted in a solvent at elevated temperatures with a basic ketone or aldehyde of the general formula where the residues R^ to R^, R^ and R^ and n have the meanings indicated above, and optionally, a possibly formed mixture of the cis and trans isomers is then separated by fractional crystallization, and/or optionally, the compound of formula I obtained is transferred to its acid addition salt by means of an inorganic or organic acid. 2. Fremgangsmåte som angitt i krav 1 for fremstilling av 2-[o-(2-dimetylaminoetoksy)styryl]-pyridin og salter derav, karakterisert ved at det anvendes utgangsmaterialer imed de generelle formler II - XI hvor til R^ hver er hydrogen, Rg og R7 er hver metyl, Ar er 2-pyridyl, ..og n er 0.2. Process as stated in claim 1 for the production of 2-[o-(2-dimethylaminoethoxy)styryl]-pyridine and salts thereof, characterized in that starting materials of the general formulas II - XI are used where R^ is each hydrogen, Rg and R7 are each methyl, Ar is 2-pyridyl, ..and n is 0.
NO3005/70A 1969-08-05 1970-08-04 NO135243C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1939809A DE1939809B2 (en) 1969-08-05 1969-08-05 β-Aryl-2-aminoalkoxy-styrenes and process for their preparation

Publications (2)

Publication Number Publication Date
NO135243B true NO135243B (en) 1976-11-29
NO135243C NO135243C (en) 1977-03-09

Family

ID=5741970

Family Applications (1)

Application Number Title Priority Date Filing Date
NO3005/70A NO135243C (en) 1969-08-05 1970-08-04

Country Status (25)

Country Link
JP (6) JPS4941433B1 (en)
KR (1) KR780000113B1 (en)
AT (5) AT302344B (en)
BE (1) BE754405A (en)
BG (6) BG17951A3 (en)
CH (6) CH548366A (en)
CS (6) CS170537B2 (en)
DE (1) DE1939809B2 (en)
DK (1) DK139717B (en)
ES (6) ES382425A1 (en)
FI (1) FI54912C (en)
FR (1) FR2068463B1 (en)
GB (1) GB1307436A (en)
HU (1) HU163185B (en)
IE (1) IE34634B1 (en)
IL (1) IL35047A (en)
NL (1) NL7011590A (en)
NO (1) NO135243C (en)
PH (1) PH9520A (en)
PL (2) PL93130B1 (en)
RO (5) RO57793A (en)
SE (1) SE382211B (en)
SU (3) SU432712A3 (en)
YU (2) YU198170A (en)
ZA (1) ZA705411B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50139537A (en) * 1974-04-25 1975-11-07
US4220603A (en) * 1977-10-07 1980-09-02 Mitsubishi Chemical Industries, Limited Pharmaceutically active (omega-aminoalkoxy)bibenzyls
JPS6045632B2 (en) * 1978-03-09 1985-10-11 三菱化学株式会社 ω-aminoalkoxystilbenes and their acid addition salts
DE2818765A1 (en) 1978-04-28 1979-11-08 Basf Ag AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRENE) -1,3,4-THIADIAZOLE
DE2818999A1 (en) * 1978-04-29 1979-11-15 Basf Ag AMINO DERIVATIVES OF 3-ALKYL-5- (2-HYDROXYSTYRYL) -ISOXAZOLES
DE2818998A1 (en) * 1978-04-29 1979-11-15 Basf Ag 3-ALKYL-5- (2-HYDROXY-STYRYL) -ISOXAZOLES AND METHOD FOR THE PRODUCTION THEREOF
JPS5629548A (en) * 1979-08-16 1981-03-24 Mitsubishi Chem Ind Ltd Omega-aminoalkoxystilbenes and their acid addition salts
DE2943406A1 (en) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRYL) -1,3,4-THIADIAZOL
DE2943405A1 (en) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen NEW AMINO DERIVATIVES OF 5- (2-HYDROXYSTYRYL) -ISOXAZOLE
DE3006809A1 (en) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2 - ((3-AMINO-2-HYDROXY-PROPOXY) -STYRYL) -ISOXAZOLES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
JPS5874379U (en) * 1981-11-16 1983-05-19 富士通株式会社 electronic equipment
NZ213986A (en) * 1984-10-30 1989-07-27 Usv Pharma Corp Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such
PL3284449T3 (en) 2011-06-10 2020-03-31 The Procter & Gamble Company Disposable diapers
SG195105A1 (en) 2011-06-10 2013-12-30 Procter & Gamble Absorbent core for disposable absorbent articles
MX2013014588A (en) 2011-06-10 2014-01-24 Procter & Gamble Absorbent structure for absorbent articles.
EP2740449B1 (en) 2012-12-10 2019-01-23 The Procter & Gamble Company Absorbent article with high absorbent material content
PL3254656T3 (en) 2013-06-14 2022-01-10 The Procter & Gamble Company Absorbent article and absorbent core forming channels when wet
US9987176B2 (en) 2013-08-27 2018-06-05 The Procter & Gamble Company Absorbent articles with channels
EP2851048B1 (en) 2013-09-19 2018-09-05 The Procter and Gamble Company Absorbent cores having material free areas
PL2886092T3 (en) 2013-12-19 2017-03-31 The Procter And Gamble Company Absorbent cores having channel-forming areas and c-wrap seals

Also Published As

Publication number Publication date
BG17950A3 (en) 1974-03-05
ES382427A1 (en) 1972-11-16
SU450398A3 (en) 1974-11-15
ES382428A1 (en) 1972-11-16
AT303055B (en) 1972-11-10
HU163185B (en) 1973-06-28
FR2068463A1 (en) 1971-08-27
IL35047A0 (en) 1970-10-30
DK139717B (en) 1979-04-02
DE1939809B2 (en) 1978-04-13
FR2068463B1 (en) 1974-08-30
BE754405A (en) 1971-02-04
JPS4941433B1 (en) 1974-11-08
IL35047A (en) 1973-05-31
JPS5113146B1 (en) 1976-04-26
CH548368A (en) 1974-04-30
SU439966A3 (en) 1974-08-15
PL78370B1 (en) 1975-06-30
YU37478A (en) 1979-07-10
FI54912B (en) 1978-12-29
JPS5113147B1 (en) 1976-04-26
BG18599A3 (en) 1975-02-25
BG20095A3 (en) 1975-10-30
AT302346B (en) 1972-10-10
RO58861A2 (en) 1975-06-30
CH548981A (en) 1974-05-15
RO58837A (en) 1975-09-15
CH548983A (en) 1974-05-15
NL7011590A (en) 1971-02-09
RO57548A (en) 1975-02-15
AT302345B (en) 1972-10-10
CH548366A (en) 1974-04-30
RO57794A (en) 1975-06-15
SU428597A3 (en) 1974-05-15
DE1939809A1 (en) 1971-02-18
SE382211B (en) 1976-01-19
AT302344B (en) 1972-10-10
FI54912C (en) 1979-04-10
ES382430A1 (en) 1972-12-01
CS170535B2 (en) 1976-08-27
RO57793A (en) 1975-03-15
AT301565B (en) 1972-09-11
YU198170A (en) 1979-07-10
BG17952A3 (en) 1974-03-05
NO135243C (en) 1977-03-09
CH548982A (en) 1974-05-15
ES382426A1 (en) 1972-11-16
JPS5113149B1 (en) 1976-04-26
CS170538B2 (en) 1976-08-27
PL93130B1 (en) 1977-05-30
BG17951A3 (en) 1974-03-05
JPS5113148B1 (en) 1976-04-26
DE1939809C3 (en) 1979-01-11
IE34634L (en) 1971-02-05
BG18600A3 (en) 1975-02-25
CS170537B2 (en) 1976-08-27
IE34634B1 (en) 1975-07-09
PH9520A (en) 1976-01-09
CS170536B2 (en) 1976-08-27
DK139717C (en) 1979-09-17
ZA705411B (en) 1971-05-27
KR780000113B1 (en) 1978-04-15
SU439965A3 (en) 1974-08-15
JPS5113150B1 (en) 1976-04-26
ES382425A1 (en) 1972-11-16
CS170533B2 (en) 1976-08-27
CH548367A (en) 1974-04-30
GB1307436A (en) 1973-02-21
ES382429A1 (en) 1972-11-16
CS170534B2 (en) 1976-08-27
SU432712A3 (en) 1974-06-15

Similar Documents

Publication Publication Date Title
NO135243B (en)
US2703324A (en) Basic ethers of aralkyl phenols and salts thereof
NO145657B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE ALKENDER DERIVATIVES.
NO141487B (en) WIRELESS INFORMATION TRANSMISSION SYSTEM
NO162965B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALFA- (2-OXO-2,4,5,6,7,7A-HEXSAHYDROTIENO- (3,2-C) -5-PYRIDYL) -PHENYL-ACETIC ACID DERIVATIVES.
NO792020L (en) PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE PHENYL PIPERAZINES
US3940386A (en) Substituted cinnamoyl-piperazine-pyridyl compound
MX2012005189A (en) Ire-1 î± inhibitors.
DK150196B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 0- (3-AMINO-2-HYDROXYPROPYL) AMIDOXIME DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
WO2013075645A1 (en) 6-substituted phenyl quinazolone compound and use thereof
NO137965B (en) ANALOGICAL PROCEDURES FOR THE PREPARATION OF NEW CYCLIC THERAPEUTIC ACTIVE DIRECTIVE DERIVATIVES AND SALTS OF THESE WITH PHARMACEUTICAL ACCEPTABLE ACIDS
DK149947B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 1,5-DIPHENYLPYRAZOLINE-3-ON COMPOUNDS OR ACID ADDITION SALTS.
US2679501A (en) Amino derivatives of 2-substituted-4-tert. butylphenol ethers
JPS61129172A (en) Heterocyclic herbicide
CA2001182A1 (en) Pyridylketoxime ether compound and pharmaceutical composition containing it
FI62062B (en) REFERENCE FOR THERAPEUTIC USE OF THERAPEUTIC ANALYSIS 3, -DICHLOROPHENONE-0- (2-AMINOETHYL) -OXIMER
CA2071497A1 (en) 2-substituted 4,5-diphenyl-imidazoles
CA2071398A1 (en) Aminomethyl-substituted 2,3-dihydropyrano/2,3-b/pyridines, process for their preparation and their use in medicaments
NO158184B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC EFFECTIVE 1-PHENYLINDAZOL-3-ON COMPOUNDS AND THEIR SALTS.
DK159850B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHENYLOIC ACETIC ACID DERIVATIVES
US2769808A (en) Dioxolane compounds
NO133708B (en)
Heyes et al. 74. An investigation of the reactions of phenyl-lithium with some methylpyrimidines
NO149209B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1- (3- (3,4,5-TRIMETOXYPHENOXY) -2-HYDROXYPROPYL) - 4-ARYL-PIPERAZINE DERIVATIVES
DK150602B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF AMINO DERIVATIVES OF 3-ALKYL-5- (2-HYDROXY-STYRYL) -ISOXAZOLES OR PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALTS